Unnamed: 0,title,date,stock,sentiment
54877.0,What Chapter 11 Bankruptcy Filings Mean For Investors,2020-06-03 09:40:00-04:00,AKRX,neutral
54878.0,33 Stocks Moving in Wednesday's Pre-Market Session,2020-05-27 07:19:00-04:00,AKRX,neutral
54879.0,96 Biggest Movers From Yesterday,2020-05-27 04:20:00-04:00,AKRX,neutral
54880.0,61 Stocks Moving In Tuesday's Mid-Day Session,2020-05-26 12:29:00-04:00,AKRX,neutral
54881.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as equities rally on coronavirus vaccine hopes as well as a pickup in economic activity as some US states reopen businesses.,2020-05-26 11:58:00-04:00,AKRX,positive
54882.0,28 Stocks Moving in Tuesday's Pre-Market Session,2020-05-26 07:18:00-04:00,AKRX,neutral
54883.0,"The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray",2020-05-22 07:10:00-04:00,AKRX,neutral
54884.0,64 Biggest Movers From Yesterday,2020-05-22 05:26:00-04:00,AKRX,neutral
54885.0,51 Stocks Moving In Thursday's Mid-Day Session,2020-05-21 13:18:00-04:00,AKRX,neutral
54886.0,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",2020-05-21 08:01:00-04:00,AKRX,neutral
54887.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-05-21 07:38:00-04:00,AKRX,neutral
54888.0,28 Stocks Moving in Thursday's Pre-Market Session,2020-05-21 07:17:00-04:00,AKRX,neutral
54889.0,Akorn Files for Voluntary Protection Under Chapter 11,2020-05-21 05:48:00-04:00,AKRX,neutral
54890.0,75 Biggest Movers From Yesterday,2020-05-14 04:26:00-04:00,AKRX,neutral
54891.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,AKRX,negative
54892.0,50 Stocks Moving In Wednesday's Mid-Day Session,2020-05-13 12:41:00-04:00,AKRX,neutral
54893.0,50 Stocks Moving In Wednesday's Mid-Day Session,2020-05-13 12:41:00-04:00,AKRX,neutral
54894.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-05-13 07:17:00-04:00,AKRX,neutral
54895.0,84 Biggest Movers From Yesterday,2020-05-13 05:31:00-04:00,AKRX,neutral
54896.0,60 Stocks Moving In Tuesday's Mid-Day Session,2020-05-12 12:26:00-04:00,AKRX,neutral
54897.0,20 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-05-12 07:33:00-04:00,AKRX,neutral
54898.0,32 Stocks Moving in Tuesday's Pre-Market Session,2020-05-12 07:16:00-04:00,AKRX,neutral
54899.0,"Akorn Q1 EPS $0.360 Up From $(0.100) YoY, Sales $204.700M Up From $165.871M YoY",2020-05-11 17:15:00-04:00,AKRX,neutral
54900.0,98 Biggest Movers From Friday,2020-05-04 05:08:00-04:00,AKRX,neutral
54901.0,58 Stocks Moving In Friday's Mid-Day Session,2020-05-01 12:39:00-04:00,AKRX,neutral
54902.0,20 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-05-01 07:42:00-04:00,AKRX,neutral
54903.0,32 Stocks Moving in Friday's Pre-Market Session,2020-05-01 07:15:00-04:00,AKRX,neutral
54904.0,20 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-04-23 07:31:00-04:00,AKRX,neutral
54905.0,78 Biggest Movers From Yesterday,2020-04-21 04:32:00-04:00,AKRX,neutral
54906.0,54 Stocks Moving In Monday's Mid-Day Session,2020-04-20 12:43:00-04:00,AKRX,neutral
54907.0,35 Stocks Moving in Monday's Pre-Market Session,2020-04-20 07:20:00-04:00,AKRX,neutral
54908.0,Shares of several healthcare companies are trading higher amid optimistic coronavirus outlook following positive drug data from Gilead. This has raised hopes of a sooner return to spending and economic activity.,2020-04-17 10:04:00-04:00,AKRX,positive
54909.0,"The Daily Biotech Pulse: FDA Nod For UroGen, Novavax Coronavirus Vaccine To Enter Clinics, Soligenix Licenses Vaccine Adjuvant",2020-04-16 08:09:00-04:00,AKRX,neutral
54910.0,Stocks That Hit 52-Week Lows On Wednesday,2020-04-15 11:46:00-04:00,AKRX,negative
54911.0,30 Stocks Moving in Wednesday's Pre-Market Session,2020-04-15 07:04:00-04:00,AKRX,neutral
54912.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-04-13 07:39:00-04:00,AKRX,neutral
54913.0,17 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-04-03 07:38:00-04:00,AKRX,neutral
54914.0,60 Stocks Moving In Thursday's Mid-Day Session,2020-04-02 12:40:00-04:00,AKRX,neutral
54915.0,30 Stocks Moving in Thursday's Pre-Market Session,2020-04-02 07:16:00-04:00,AKRX,neutral
54916.0,Akorn Inc Earlier Announced No Longer Has Any Bids In Sale Process That Are Sufficient To Pay All Obligations Under Its Term Loan Agreement,2020-04-01 07:56:00-04:00,AKRX,positive
54917.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-04-01 07:45:00-04:00,AKRX,neutral
54918.0,90 Biggest Movers From Yesterday,2020-03-27 04:01:00-04:00,AKRX,neutral
54919.0,60 Stocks Moving In Thursday's Mid-Day Session,2020-03-26 12:33:00-04:00,AKRX,neutral
54920.0,Akorn shares are trading higher following unconfirmed rumors suggesting Cerberus and Vivo Capital could be exploring a bid for the company.,2020-03-26 09:39:00-04:00,AKRX,positive
54921.0,"Cerberus, Vivo Capital Exploring Bid For Akorn",2020-03-26 07:50:00-04:00,AKRX,neutral
54922.0,17 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-03-26 07:39:00-04:00,AKRX,neutral
54923.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,AKRX,negative
54924.0,"The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO",2020-03-12 07:37:00-04:00,AKRX,negative
54925.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-11 11:41:00-04:00,AKRX,negative
54926.0,Stocks That Hit 52-Week Lows On Tuesday,2020-03-10 10:37:00-04:00,AKRX,negative
54927.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,AKRX,negative
54928.0,"The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies",2020-03-04 07:37:00-05:00,AKRX,negative
54929.0,Stocks That Hit 52-Week Lows On Tuesday,2020-03-03 10:47:00-05:00,AKRX,negative
54930.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,AKRX,positive
54931.0,Akorn shares are trading lower. The company late Wednesday reported Q4 earnings. NOTE: Global equities are steeply lower today amid a coronavirus-driven sell off.,2020-02-27 11:42:00-05:00,AKRX,negative
54932.0,Stocks That Hit 52-Week Lows On Thursday,2020-02-27 10:23:00-05:00,AKRX,negative
54933.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,AKRX,positive
54934.0,"Akorn Q4 Adj. EPS $(0.07) Up From $(0.29) YoY, Sales $162.3M Up From $153.386M YoY",2020-02-26 17:02:00-05:00,AKRX,neutral
54935.0,77 Biggest Movers From Yesterday,2020-02-14 04:59:00-05:00,AKRX,neutral
54936.0,58 Stocks Moving In Thursday's Mid-Day Session,2020-02-13 12:22:00-05:00,AKRX,neutral
54937.0,Akorn shares are trading lower after the company reported a deal with certain lenders to extend its standstill period and agreed to pursue a sale of the company.,2020-02-13 09:26:00-05:00,AKRX,positive
54938.0,13 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-13 07:34:00-05:00,AKRX,neutral
54939.0,36 Stocks Moving in Thursday's Pre-Market Session,2020-02-13 07:32:00-05:00,AKRX,neutral
54940.0,Akorn Reports Deal With Certain Lenders To Extend Standstill Period; To Pursue Sale Of Co.,2020-02-12 17:31:00-05:00,AKRX,positive
54941.0,Akorn Confirms Negotiations With Certain Lenders Are Ongoing Following Expiration Of Standstill Agreement On Feb. 7,2020-02-10 07:04:00-05:00,AKRX,positive
54942.0,4 Specialty & Generic Drug Manufacturer Stocks Moving In Monday's After-Market Session,2020-01-27 23:48:00-05:00,AKRX,neutral
54943.0,36 Healthcare Stocks Moving In Monday's After-Market Session,2020-01-27 23:41:00-05:00,AKRX,neutral
54944.0,50 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-01-08 08:31:00-05:00,AKRX,neutral
54945.0,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",2020-01-07 07:57:00-05:00,AKRX,negative
54946.0,"The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe",2020-01-02 08:46:00-05:00,AKRX,negative
54947.0,Stocks That Hit 52-Week Lows On Friday,2019-12-27 11:40:00-05:00,AKRX,negative
54948.0,"The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping",2019-12-27 07:59:00-05:00,AKRX,neutral
54949.0,"The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares",2019-12-26 07:55:00-05:00,AKRX,negative
54950.0,"The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict",2019-12-24 07:24:00-05:00,AKRX,negative
54951.0,Stocks That Hit 52-Week Lows On Friday,2019-12-20 12:13:00-05:00,AKRX,negative
54952.0,Shares of small-cap biotech company Akorn are trading lower. Not currently seeing any company-specific news.,2019-12-20 10:01:00-05:00,AKRX,neutral
54953.0,68 Biggest Movers From Yesterday,2019-12-20 04:34:00-05:00,AKRX,neutral
54954.0,28 Stocks Moving in Thursday's Pre-Market Session,2019-12-19 08:13:00-05:00,AKRX,neutral
54955.0,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",2019-12-19 07:52:00-05:00,AKRX,negative
54956.0,64 Biggest Movers From Yesterday,2019-12-19 05:03:00-05:00,AKRX,neutral
54957.0,Mid-Afternoon Market Update: FedEx Falls On Earnings Miss; Neoleukin Therapeutics Shares Climb,2019-12-18 14:10:00-05:00,AKRX,positive
54958.0,40 Stocks Moving In Wednesday's Mid-Day Session,2019-12-18 12:04:00-05:00,AKRX,neutral
54959.0,Akorn shares are trading lower following a bearish SeekingAlpha article that warns of possible bankruptcy.,2019-12-18 11:39:00-05:00,AKRX,negative
54960.0,"BZ NOTE On Akorn Price Action Wed., Seeking Alpha Post: Post Mentions 8-K Filing Which Was From Mon. Morning; Shares Of Akorn Did Not React Sharply Mon., However Are Down 32% This Week",2019-12-18 11:10:00-05:00,AKRX,positive
54961.0,"Akorn Shares Down 22% For Session, Downside Intensifying Over Last Few Mins As Traders Circulate Earlier Seeking Alpha Blogpost From Hugh Akston 'Akorn Warns Of Possible Bankruptcy Filing'",2019-12-18 11:07:00-05:00,AKRX,negative
54962.0,Mid-Morning Market Update: Markets Edge Higher; General Mills Earnings Beat Expectations,2019-12-18 10:39:00-05:00,AKRX,neutral
54963.0,Akorn shares are trading lower. Not seeing any news to justify the price action.,2019-12-17 11:30:00-05:00,AKRX,neutral
54964.0,Akorn shares are trading higher. This could potentially be a rebound after the stock dropped approximately 25% over the past 14 trading sessions.,2019-11-25 11:48:00-05:00,AKRX,positive
54965.0,"Akorn Q3 EPS $0.02 Beats $(0.04) Estimate, Sales $176.244M Beat $176.09M Estimate; Reaffirms FY19 Guidance: Sales $690M-$710M, Adj. EBITDA $71M-$86M",2019-10-31 09:18:00-04:00,AKRX,neutral
54966.0,"The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut",2019-10-31 08:08:00-04:00,AKRX,positive
54967.0,Mid-Morning Market Update: Gold Trades Higher; Amazon Shares Tumble,2019-10-25 10:14:00-04:00,AKRX,positive
54968.0,17 Stocks Moving in Friday's Pre-Market Session,2019-10-25 08:44:00-04:00,AKRX,neutral
54969.0,48 Biggest Movers From Yesterday,2019-10-18 06:55:00-04:00,AKRX,neutral
54970.0,Akorn shares are trading higher on continued momentum after the company reported it received FDA approval for its Betamethasone Dipropionate Lotion USP 0.05%.,2019-10-17 14:08:00-04:00,AKRX,positive
54971.0,Akorn shares are trading higher after the company reported it received FDA approval for its Betamethasone Dipropionate Lotion USP 0.05%.,2019-10-15 08:22:00-04:00,AKRX,positive
54972.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-15 08:04:00-04:00,AKRX,neutral
54973.0,"The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings",2019-10-15 07:50:00-04:00,AKRX,positive
54974.0,25 Stocks Moving in Tuesday's Pre-Market Session,2019-10-15 07:44:00-04:00,AKRX,neutral
54975.0,"10 Stocks To Watch For October 15, 2019",2019-10-15 04:34:00-04:00,AKRX,neutral
54976.0,Akorn shares are trading higher after the company reported it received FDA approval for its Betamethasone Dipropionate Lotion USP 0.05%.,2019-10-14 16:28:00-04:00,AKRX,positive
54977.0,"Akorn Reports FDA Approval For Betamethasone Dipropionate Lotion USP, 0.05%",2019-10-14 16:25:00-04:00,AKRX,positive
54978.0,Akorn shares are trading higher despite no company-specific news. The stock has rallied approximately 48% in the last month.,2019-09-27 11:04:00-04:00,AKRX,positive
54979.0,"Top 10 Most Overbought Stocks Via Benzinga Pro's Screener Tool For Tue., September 24, 2019",2019-09-24 14:03:00-04:00,AKRX,positive
54980.0,45 Biggest Movers From Friday,2019-09-23 06:08:00-04:00,AKRX,neutral
54981.0,Mid-Afternoon Market Update: U.S. Stocks Turn Lower; Roku Shares Plummet,2019-09-20 14:41:00-04:00,AKRX,neutral
54982.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,AKRX,negative
54983.0,Akorn shares are trading higher after SunTrust Robinson Humphrey maintained a hold rating and raised the price target from $3.50 to $4.,2019-09-20 10:17:00-04:00,AKRX,positive
54984.0,"SunTrust Robinson Humphrey Maintains Hold on Akorn, Raises Price Target to $4",2019-09-20 08:35:00-04:00,AKRX,neutral
54985.0,80 Biggest Movers From Yesterday,2019-09-11 05:11:00-04:00,AKRX,neutral
54986.0,Akorn 8-K Shows Investor Presentation Slideshow Including FY20 Guidance For Adj. EBITDA Growth To At Least Double From FY19,2019-09-10 17:53:00-04:00,AKRX,positive
54987.0,50 Stocks Moving In Tuesday's Mid-Day Session,2019-09-10 12:19:00-04:00,AKRX,neutral
54988.0,Akorn Shares Spike To Near-Session High As Questionable Source Interconomia Highlighting Chatter Of PE Interest,2019-09-03 10:46:00-04:00,AKRX,positive
54989.0,50 Biggest Movers From Yesterday,2019-08-27 05:20:00-04:00,AKRX,neutral
54990.0,Akorn shares are trading higher after the company received FDA Abbreviated New Drug Application approval for Azelastine Hydrochloride Nasal Spray.,2019-08-26 14:06:00-04:00,AKRX,positive
54991.0,"Akorn Receives A New Abbreviated New Drug Application Approval From The FDA For Azelastine Hydrochloride Nasal Spray, 0.15%",2019-08-26 13:36:00-04:00,AKRX,positive
54992.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,2019-08-19 12:31:00-04:00,AKRX,positive
54993.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal.",2019-08-16 13:27:00-04:00,AKRX,negative
54994.0,"The Daily Biotech Pulse: Mallinkckrodt's Terlipressin, Deciphera Offering, Sellas Reboots On Earnings",2019-08-15 07:45:00-04:00,AKRX,neutral
54995.0,Akorn 8-K Shows Stipulation And Agreement Of Settlement In Data Integrity Securities Litigation,2019-08-12 06:24:00-04:00,AKRX,positive
54996.0,Akorn Sees FY19 Sales $690M-$710M vs $692.99M Est.,2019-08-01 07:54:00-04:00,AKRX,neutral
54997.0,"Akorn Q2 EPS $(0.89) Misses $(0.07) Estimate, Sales $178.06M Beat $171.91M Estimate",2019-08-01 07:53:00-04:00,AKRX,negative
54998.0,"The Daily Biotech Pulse: Exelixis Signs Cancer Drug Licensing Deal, Adamis Offering, Surmodics Surges On Earnings",2019-08-01 07:18:00-04:00,AKRX,negative
54999.0,"The Week Ahead In Biotech: Pending Clinical Readouts, Earnings Dominate",2019-07-27 14:32:00-04:00,AKRX,negative
55000.0,Akorn Option Alert: Jan 17 $4.5 Calls at the Ask: 15000 @ $0.551 vs 1 OI; Earnings 8/1 Before Open Ref=$3.49,2019-07-25 13:27:00-04:00,AKRX,positive
55001.0,Shares of several drug manufacturing companies are trading lower. The Trump Administration earlier rolled back a proposal to eliminate rebates from government drug plans and commented on continued efforts to lower drug prices.,2019-07-11 10:36:00-04:00,AKRX,negative
55002.0,Akorn Highlights Launch Of Loteprednol Etabonate Ophthalmic Suspension,2019-06-28 07:02:00-04:00,AKRX,neutral
55003.0,62 Biggest Movers From Yesterday,2019-06-28 05:20:00-04:00,AKRX,neutral
55004.0,48 Stocks Moving In Thursday's Mid-Day Session,2019-06-27 12:41:00-04:00,AKRX,neutral
55005.0,"Akorn Receives FDA Warning Letter, Says It's Committed To Resolving Issues",2019-06-25 11:00:00-04:00,AKRX,positive
55006.0,Akorn Shares Resume Trade,2019-06-25 07:58:00-04:00,AKRX,positive
55007.0,"Akorn Receives A Warning Letter From FDA Related To The Inspection Of Its Somerset, New Jersey Manufacturing Facility In July And August Of 2018.",2019-06-25 07:37:00-04:00,AKRX,negative
55008.0,"Akorn Shares Halted, News Pending",2019-06-25 07:36:00-04:00,AKRX,positive
55009.0,40 Stocks Moving In Wednesday's Mid-Day Session,2019-06-19 12:23:00-04:00,AKRX,neutral
55010.0,"The Daily Biotech Pulse: Setback For Merck In Breast Cancer Study, Arrowhead to Join S&P SmallCap 600 Index, Ocular's Glaucoma Trial Fails",2019-05-21 07:40:00-04:00,AKRX,negative
55011.0,"Acorn Shares Spike To Session High On Volume, Now Up 1.4%; Traders Circulate Access Data FDA Doc Showing Orange Book Approval Of Its Azelastine Hydrochloride",2019-05-20 14:40:00-04:00,AKRX,positive
55012.0,95 Biggest Movers From Yesterday,2019-05-09 05:01:00-04:00,AKRX,neutral
55013.0,75 Stocks Moving In Wednesday's Mid-Day Session,2019-05-08 12:24:00-04:00,AKRX,neutral
55014.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wed., May 8, 2019",2019-05-08 10:45:00-04:00,AKRX,positive
55015.0,72 Biggest Movers From Yesterday,2019-05-08 06:17:00-04:00,AKRX,neutral
55016.0,64 Stocks Moving In Tuesday's Mid-Day Session,2019-05-07 12:17:00-04:00,AKRX,neutral
55017.0,Akorn shares are trading higher after the company reported better-than-expected Q1 EPS and sales results and issued FY19 sales guidance above the consensus estimates.,2019-05-07 09:32:00-04:00,AKRX,positive
55018.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,AKRX,neutral
55019.0,31 Stocks Moving In Tuesday's Pre-Market Session,2019-05-07 08:05:00-04:00,AKRX,neutral
55020.0,Akorn Sees FY19 Sales $690M-$710M vs $633.47M Est.,2019-05-07 07:07:00-04:00,AKRX,neutral
55021.0,"Akorn, Inc. Q1 Adj. EPS $(0.1) Beats $(0.2) Estimate, Sales $166M Beat $153.52M Estimate",2019-05-07 07:06:00-04:00,AKRX,neutral
55022.0,Akorn Shares Getting A Spike As Traders Ciculate Unconfirmed Chatter Indicating Co. Received A $4/Share Takeover Approach,2019-04-25 13:40:00-04:00,AKRX,positive
55023.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tue., Apr. 23, 2019",2019-04-23 10:17:00-04:00,AKRX,positive
55024.0,45 Biggest Movers From Yesterday,2019-04-23 05:59:00-04:00,AKRX,neutral
55025.0,34 Stocks Moving In Monday's Mid-Day Session,2019-04-22 12:17:00-04:00,AKRX,neutral
55026.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Mon., Apr. 22, 2019",2019-04-22 10:22:00-04:00,AKRX,positive
55027.0,Akorn Receives 2 Generic Nose Spray Approvals,2019-04-22 09:28:00-04:00,AKRX,neutral
55028.0,30 Stocks Moving In Monday's Pre-Market Session,2019-04-22 08:16:00-04:00,AKRX,neutral
55029.0,Akorn shares are trading higher after the FDA approved the company's new drug application for Fluticasone Nasal Spray USP.,2019-04-22 07:55:00-04:00,AKRX,positive
55030.0,Akorn shares are trading higher after the company received FDA approval for Fluticasone nasal spray.,2019-04-18 16:10:00-04:00,AKRX,positive
55031.0,"Akorn Reports FDA Approval For Fluticasone Propionate Nasal Spray, 50 mcg/Spray",2019-04-18 16:06:00-04:00,AKRX,positive
55032.0,"Akorn Shares Make Parabolic Move Over Last Few Mins., Have Now Sold Off Further, Stock At Session Lows; Hearing Chatter Generic For Flonase Was Approved",2019-04-18 14:56:00-04:00,AKRX,positive
55033.0,"The Daily Biotech Pulse: Merck's Keytruda Clinches Another FDA Win, KemPharm Close To NDA Filing For ADHD Drug",2019-04-12 07:47:00-04:00,AKRX,positive
55034.0,"Acorn Shares Dip Sharply Lower, Immediately Rebound And Now Largely Unaffected Following Circulation Of Trader Chatter FDA Sent A Form 483 To Co., Cited 13 Observations",2019-04-01 11:14:00-04:00,AKRX,neutral
55035.0,"SunTrust Robinson Humphrey Initiates Coverage On Akorn with Hold Rating, Announces $4 Price Target",2019-03-20 07:21:00-04:00,AKRX,neutral
55036.0,"Baxter International Says Is Not In Advanced Talks With Akorn, Nor Does Have Any Intention To Submit Offer To Acquire Akorn",2019-03-12 15:22:00-04:00,AKRX,negative
55037.0,Intereconomia Reports Baxter Is In Talks To Buy Akorn,2019-03-12 12:05:00-04:00,AKRX,neutral
55038.0,Hearing Akorn Therapeutics Received FDA Approval For Phenylephrine Hydrochloride; Unconfirmed,2019-03-04 14:10:00-05:00,AKRX,positive
55039.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,AKRX,positive
55040.0,"Akorn, Inc. Q4 EPS $(0.29) Down From $0.14 YoY, Sales $153.386M Miss $164.74M Estimate",2019-02-28 07:28:00-05:00,AKRX,negative
55041.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,AKRX,neutral
55042.0,75 Biggest Movers From Yesterday,2019-02-21 05:12:00-05:00,AKRX,neutral
55043.0,"Akorn Says Strongly Contests Fresenius' Proposed Amended Claims Filed Wed., Says Claims 'Meritless,' 'Overreaching'",2019-02-20 17:29:00-05:00,AKRX,positive
55044.0,Akorn Shares Volatile Here But Largely Unchanged As Traders Circulate Unconfirmed Word Of FDA Warning Letter,2019-02-13 10:57:00-05:00,AKRX,negative
55045.0,56 Biggest Movers From Yesterday,2019-01-10 05:16:00-05:00,AKRX,neutral
55046.0,45 Stocks Moving In Wednesday's Mid-Day Session,2019-01-09 12:31:00-05:00,AKRX,neutral
55047.0,Akorn Slides After Reporting FDA Warning Letter On Illinois Facility,2019-01-09 12:09:00-05:00,AKRX,negative
55048.0,"Akorn shares are trading lower after the company received an FDA warning letter related to a prior inspection of its Decatur, Illinois manufacturing facility in April and May of 2018.",2019-01-09 10:38:00-05:00,AKRX,negative
55049.0,Akorn Shares Now Down ~21%,2019-01-09 08:25:00-05:00,AKRX,positive
55050.0,"Akorn Shares Resume Trade, Down ~12%",2019-01-09 08:25:00-05:00,AKRX,positive
55051.0,Akorn Shares Were Halted At ~7:54 a.m. EST To Announce FDA Warning Letter; Stock To Resume Trade At 8:25 a.m. EST,2019-01-09 08:04:00-05:00,AKRX,negative
55052.0,Akorn Receives FDA Warning Letter,2019-01-09 07:55:00-05:00,AKRX,negative
55053.0,"Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019",2019-01-02 13:08:00-05:00,AKRX,negative
55054.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,AKRX,neutral
55055.0,"Akorn Names Douglas Boothe Pres, CEO",2018-12-20 17:05:00-05:00,AKRX,neutral
55056.0,48 Biggest Movers From Friday,2018-12-10 05:23:00-05:00,AKRX,neutral
55057.0,Fresenius Says: Delaware Supreme Court Upholds Fresenius' Termination Of Merger Agreement With Akorn,2018-12-07 12:54:00-05:00,AKRX,positive
55058.0,Akorn Therapeutics shares are trading lower following reports indicating the company has lost its bid for an acquisition by Fresenius.,2018-12-07 11:35:00-05:00,AKRX,negative
55059.0,"Akorn Therapeutics Shares Resume Trade, Down 21%",2018-12-07 10:57:00-05:00,AKRX,positive
55060.0,Akorn Shares Fall to Lows and Halted Following Bloomberg Report Co Loses Bid to Salvage Acquisition by Fresnius,2018-12-07 10:53:00-05:00,AKRX,negative
55061.0,60 Biggest Movers From Yesterday,2018-12-07 04:42:00-05:00,AKRX,neutral
55062.0,"Akorn Announces Approval Of Abbreviated New Drug Application For Diclofenac Sodium Topical Gel, 1%",2018-11-26 17:30:00-05:00,AKRX,positive
55063.0,Hearing RBC Says Akorn Received Approval For Generic Voltaren Gel; Unconfirmed,2018-11-26 15:17:00-05:00,AKRX,positive
55064.0,88 Biggest Movers From Yesterday,2018-11-08 04:54:00-05:00,AKRX,neutral
55065.0,70 Stocks Moving In Wednesday's Mid-Day Session,2018-11-07 12:52:00-05:00,AKRX,neutral
55066.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie",2018-11-07 07:50:00-05:00,AKRX,negative
55067.0,"Akorn, Inc. - Common Stock Q3 EPS $(0.56) Down From $(0.02) YoY, Sales $165.625M Down From $202.428M YoY",2018-11-06 17:12:00-05:00,AKRX,neutral
55068.0,Stat News Publishes an Article Titled 'Akorn is tagged — again — by the FDA for problems at a manufacturing plant',2018-11-05 11:44:00-05:00,AKRX,negative
55069.0,Akorn Option Alert: Dec 21 $27.5 Calls at the Ask: 2000 @ $0.101 vs 6398 OI; Earnings 11/6 Before Open [est] Ref=$6.64,2018-10-30 13:15:00-04:00,AKRX,positive
55070.0,"Akorn Announces its Abbreviated New Drug Application Was Approved by the FDA for Clobetasol Propionate Lotion, 0.05%",2018-10-29 07:23:00-04:00,AKRX,positive
55071.0,Akorn Shares Spike 1.2% On Heavy Volume As Traders Circulate Chatter,2018-10-25 11:17:00-04:00,AKRX,positive
55072.0,"S&P Dow Jones Indices Announces Resideo Technologies Set to Join S&P MidCap 400;
Akorn to Join S&P SmallCap 600",2018-10-23 17:18:00-04:00,AKRX,positive
55073.0,Akorn-Fresenius Delivering Supreme Court Appeal Hearing Set For Dec 5,2018-10-23 14:39:00-04:00,AKRX,positive
55074.0,Akorn Reports Appealing Fresenius Kabi Ruling,2018-10-18 13:48:00-04:00,AKRX,neutral
55075.0,"Akorn Upgraded By Piper Jaffray On Improved Cost Structure, Product Potential",2018-10-17 09:41:00-04:00,AKRX,positive
55076.0,"Benzinga's Top Upgrades, Downgrades For October 17, 2018",2018-10-17 09:09:00-04:00,AKRX,positive
55077.0,31 Stocks Moving In Wednesday's Pre-Market Session,2018-10-17 08:06:00-04:00,AKRX,neutral
55078.0,"PiperJaffray Upgrades Akorn to Overweight, Announces $9 Price Target",2018-10-17 05:49:00-04:00,AKRX,negative
55079.0,Akorn Option Alert: Mar 15 $10 Calls at the Ask: 500 @ $1.4 vs 5529 OI; Earnings 10/31 Before Open [est] Ref=$5.995,2018-10-12 10:19:00-04:00,AKRX,positive
55080.0,Akorn's Generic Drug For Inadequate Eye Lashes Receives FDA Nod,2018-10-10 09:43:00-04:00,AKRX,negative
55081.0,Akorn shares are trading higher after the company's abbreviated new drug application was approved by the FDA.,2018-10-10 08:01:00-04:00,AKRX,positive
55082.0,Akorn's Ophthalmic Solution Receives Abbreviated New Drug Application Approval From FDA,2018-10-10 07:08:00-04:00,AKRX,positive
55083.0,26 Stocks Moving In Thursday's Pre-Market Session,2018-10-04 07:58:00-04:00,AKRX,neutral
55084.0,"Stocks Which Set New 52-Week Low Yesterday, October 2nd",2018-10-03 13:01:00-04:00,AKRX,negative
55085.0,"Stocks Which Set New 52-Week Low Yesterday, October 1st",2018-10-02 09:24:00-04:00,AKRX,negative
55086.0,48 Biggest Movers From Yesterday,2018-10-02 04:51:00-04:00,AKRX,neutral
55087.0,Mid-Afternoon Market Update: Crude Oil Rises 2.5%; iFresh Shares Spike Higher,2018-10-01 14:31:00-04:00,AKRX,negative
55088.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Afternoon Of Mon., Oct. 1, 2018",2018-10-01 13:17:00-04:00,AKRX,positive
55089.0,38 Stocks Moving In Monday's Mid-Day Session,2018-10-01 12:18:00-04:00,AKRX,neutral
55090.0,Mid-Day Market Update: Crude Oil Up Over 1%; Akorn Shares Plunge,2018-10-01 12:00:00-04:00,AKRX,negative
55091.0,Akorn shares are down 54.7% after a Delaware court upheld Fresenius' termination of a merger with the company.,2018-10-01 11:23:00-04:00,AKRX,positive
55092.0,Akorn Option Alert: Dec 21 $10 Puts at the Bid: 1300 @ $4.55 vs 13587 OI; Earnings 10/31 Before Open [est] Ref=$5.9601,2018-10-01 10:43:00-04:00,AKRX,positive
55093.0,Mid-Morning Market Update: Markets Open Higher; Cal-Maine Misses Q1 Views,2018-10-01 10:22:00-04:00,AKRX,negative
55094.0,"Akorn Shares Resume Trade Following Circuit Breaker, Down 55.3%",2018-10-01 10:03:00-04:00,AKRX,positive
55095.0,"Akorn Shares Resume Trade, Down 49.9%",2018-10-01 09:55:00-04:00,AKRX,positive
55096.0,Akorn To Resume Trade At 9:55 a.m. ET,2018-10-01 09:38:00-04:00,AKRX,neutral
55097.0,Akorn Offers Comment On Delaware Complaint Against Fresenius,2018-10-01 09:26:00-04:00,AKRX,negative
55098.0,Delaware Court Upholds Fresenius' Termination Of Merger Agreement With Akorn,2018-10-01 09:23:00-04:00,AKRX,positive
55099.0,"Delaware Court Rules For Fresenius In Disputed Akorn Merger; Judge Says Fresenius Validly Terminate Merger Agreement With Akorn, Says Akorn's Merger Representations To Fresenius Were Not True",2018-10-01 08:51:00-04:00,AKRX,negative
55100.0,Hearing Fresenius Has Won Ruling To Terminate Deal With Akorn -Bloomberg; Shares Now Halted With Code News Pending,2018-10-01 08:26:00-04:00,AKRX,positive
55101.0,Watching Akorn Shares As Hearing Report FDA Found Testing Operational Problems In Co.'s Plant Review,2018-09-13 15:13:00-04:00,AKRX,negative
55102.0,"Akorn Shares Spike Higher Over $13.60 Level On Very Heavy Volume, Spike As Much As 6.9%; Shares Quickly Pare Gains, Now Up Only 0.8% Over Last Few Mins.; Not Seeing News To Justify Price Action",2018-09-13 13:04:00-04:00,AKRX,positive
55103.0,Akorn Option Alert: Sep 21 $15 Calls Sweep (11) near the Ask: 731 @ $0.6 vs 16433 OI; Earnings 10/31 Before Open [est] Ref=$13.67,2018-09-11 12:48:00-04:00,AKRX,positive
55104.0,"Akorn Shares Down ~1.5% At $13.85, Hearing Judge Won't Reopen Trial For FDA Data-Review Inquiry",2018-09-11 12:39:00-04:00,AKRX,positive
55105.0,Akorn Option Alert: Sep 21 $10 Puts at the Bid: 6000 @ $0.651 vs 16191 OI; Ref=$14.48,2018-08-29 09:53:00-04:00,AKRX,positive
55106.0,42 Biggest Movers From Yesterday,2018-08-24 04:13:00-04:00,AKRX,neutral
55107.0,Akorn Option Alert: Sep 21 $20 Calls Sweep (5) near the Ask: 500 @ $1.75 vs 29702 OI; Earnings 8/27 Before Open [est] Ref=$14.49,2018-08-23 14:40:00-04:00,AKRX,positive
55108.0,"Akorn Shares Move Below $18 Level, Fall ~9% Over Last 20 Mins.; Traders Earlier Circulated Word Judge In Co./Fresenius Case Said He 'Has A Lot To Do Before' Making A Decision",2018-08-23 12:36:00-04:00,AKRX,positive
55109.0,Akorn Option Alert: Sep 21 $15 Puts at the Ask: 1050 @ $3.201 vs 14299 OI; Earnings 8/27 Before Open [est] Ref=$16.785,2018-08-23 12:31:00-04:00,AKRX,positive
55110.0,50 Biggest Movers From Yesterday,2018-08-22 04:33:00-04:00,AKRX,neutral
55111.0,Fresenius Says Mgmt. Is 'Convinced Of Merits' Of Case To Cancel Akorn Deal,2018-07-31 08:15:00-04:00,AKRX,positive
55112.0,Akorn Option Alert: Aug 17 $17.5 Calls at the Bid: 637 @ $1.25 vs 609 OI; Earnings 7/30 Before Open [est] Ref=$16.81,2018-07-17 15:16:00-04:00,AKRX,positive
55113.0,"Akorn Shares Down ~1.1% Over Last 30 Mins, Volume Came Into Issue Over Just Last Few Mins. As Traders Circulate Word Of Court Filing Showing Post-Trial Briefing Is Due By Aug. 20",2018-07-17 14:10:00-04:00,AKRX,positive
55114.0,Akorn Option Alert: Jul 20 $20 Calls at the Bid: 889 @ $2.101 vs 4955 OI; Earnings 7/30 Before Open [est] Ref=$17.86,2018-07-06 15:12:00-04:00,AKRX,positive
55115.0,Akorn Option Alert: Aug 17 $30 Calls Sweep (3) near the Ask: 1041 @ $0.75 vs 257 OI; Earnings 7/30 Before Open [est] Ref=$18.005,2018-07-06 13:54:00-04:00,AKRX,positive
55116.0,Akorn Option Alert: Jul 20 $17.5 Calls Sweep (11) near the Ask: 1390 @ $2.51 vs 739 OI; Earnings 7/30 Before Open [est] Ref=$17.14,2018-07-03 11:19:00-04:00,AKRX,positive
55117.0,Akorn Option Alert: Jul 20 $20 Calls at the Ask: 1069 @ $1.351 vs 1024 OI; Earnings 7/30 Before Open [est] Ref=$15.58,2018-06-20 14:08:00-04:00,AKRX,positive
55118.0,Akorn Shares Spike ~1% Over Last Few Mins.; Stock Now Up 4.2% For Session,2018-06-19 15:19:00-04:00,AKRX,positive
55119.0,"Benzinga's Daily Biotech Pulse: Portola Receives FDA Nod, Mallinckrodt Gets Thumbs Down",2018-05-04 08:16:00-04:00,AKRX,neutral
55120.0,Akorn Option Alert: Sep 21 $15 Calls at the Bid: 750 @ $2.201 vs 2067 OI; Earnings 5/9 Before Open [est] Ref=$11.58,2018-05-03 11:11:00-04:00,AKRX,positive
55121.0,Traders Circulating a Document From The FDA On Akorn Reporting Notes And Deficiencies At A Co. Facility From Dec. 2017,2018-05-03 10:48:00-04:00,AKRX,neutral
55122.0,Fresenius Says Delaware Court Hearing Related To Cancelled Merger Deal With Akorn Will Take Place On Jul. 9,2018-05-03 08:31:00-04:00,AKRX,negative
55123.0,55 Biggest Movers From Yesterday,2018-05-03 04:42:00-04:00,AKRX,neutral
55124.0,"Akorn Shares Spike Higher As Delaware Court Has Ordered Co., Fresenius Trial To Begin Jul. 9, Will Last 1 Week",2018-05-02 15:26:00-04:00,AKRX,positive
55125.0,UPDATE: Fresenius Says Investigation Related To Akorn Deal Uncovered Fraud,2018-05-02 09:53:00-04:00,AKRX,negative
55126.0,Akorn Shares Largely Unaffected Amid Report Co. Accused Of Submitting Phony Data To FDA Related To Its Antibiotic Drug,2018-05-02 09:52:00-04:00,AKRX,neutral
55127.0,Akorn Shares Up ~$0.50 Since Circulation Of RBC Comments Co. Deal With Fresenius 'Still Likely To Close'; Stock Up 7.5% For Session,2018-04-27 12:20:00-04:00,AKRX,positive
55128.0,Hearing RBC Says Akorn/Fresenius Deal Still Likely To Close,2018-04-27 12:17:00-04:00,AKRX,neutral
55129.0,35 Biggest Movers From Yesterday,2018-04-24 05:07:00-04:00,AKRX,neutral
55130.0,28 Stocks Moving In Monday's Mid-Day Session,2018-04-23 12:23:00-04:00,AKRX,neutral
55131.0,Akron Shares Down 28.3% After Fresenius Announced It Is Seeking To Terminate Merger Deal Announced Last Year,2018-04-23 12:05:00-04:00,AKRX,positive
55132.0,"Benzinga Pro's Most-Searched Tickers For Morning Of Mon., Apr. 23, 2018",2018-04-23 11:54:00-04:00,AKRX,neutral
55133.0,Mid-Morning Market Update: Markets Mostly Flat; Hasbro Misses Q1 Expectations,2018-04-23 10:11:00-04:00,AKRX,negative
55134.0,Akron Reports Filing Of Complaint In Delaware Court Asking Fresenius Be Required To Fulfill Obligation Under Merger Deal,2018-04-23 08:43:00-04:00,AKRX,positive
55135.0,24 Stocks Moving In Monday's Pre-Market Session,2018-04-23 08:02:00-04:00,AKRX,neutral
55136.0,Akorn Issues Statement Refuting Fresenius' Accusations,2018-04-22 17:15:00-04:00,AKRX,negative
55137.0,Akorn Option Alert: Jun 15 $20 Calls at the Ask: 1000 @ $3.8 vs 6589 OI; Earnings 5/3 Before Open [est] Ref=$18.2,2018-04-11 11:29:00-04:00,AKRX,positive
55138.0,"Fresenius Says it is Still Probing Akorn, Says Inaccurate 2014 Financial Statements are Not Related to the Probe",2018-03-27 07:18:00-04:00,AKRX,neutral
55139.0,"Hearing Akorn, Ex-CFFO Agree To Settle Accounting Control Violations",2018-03-26 14:16:00-04:00,AKRX,negative
55140.0,"Shares of Akorn Spiking Higher, Hit A High Of $19.40 Before Settling At $18.68",2018-03-26 14:15:00-04:00,AKRX,positive
55141.0,"Benzinga Pro's Top 10 Most-Searched Tickers Wed. Morning: Square, Lipocine, Macy's, Mallinckrodt, Tetraphase Pharma, Zosano Pharma, Arcadia Biosciences, DelMar Pharma, Akers Biosciences, Acorn",2018-02-28 07:17:00-05:00,AKRX,positive
55142.0,42 Biggest Movers From Yesterday,2018-02-28 04:49:00-05:00,AKRX,neutral
55143.0,Akorn Option Alert: Jun 15 $17.5 Puts at the Ask: 1000 @ $3.701 vs 107 OI; Earnings 3/6 Before Open [est] Ref=$19.295,2018-02-27 14:35:00-05:00,AKRX,positive
55144.0,Mid-Afternoon Market Update: Crude Oil Down 1.5%; Mallinckrodt Shares Climb After Strong Q4 Results,2018-02-27 14:30:00-05:00,AKRX,positive
55145.0,"Akorn Shares Down 34% After Fresenius Kabi Announced Investigation Into Alleged Breaches Of FDA Data Integrity Requirements; Co. Issued Response, Said Probe Has Not Found Any Facts That Would Result In Material Impact",2018-02-27 12:35:00-05:00,AKRX,positive
55146.0,35 Stocks Moving In Tuesday's Mid-Day Session,2018-02-27 12:32:00-05:00,AKRX,neutral
55147.0,Mid-Day Market Update: U.S. Stocks Turn Lower; Dillard's Shares Gain On Earnings Beat,2018-02-27 12:00:00-05:00,AKRX,positive
55148.0,Mid-Morning Market Update: Markets Open Higher; Macy's Profit Tops Estimates,2018-02-27 10:20:00-05:00,AKRX,positive
55149.0,"Fresenius Investigates Akorn FDA Compliance, Says Outcome May Affect Merger",2018-02-27 08:12:00-05:00,AKRX,neutral
55150.0,22 Stocks Moving In Tuesday's Pre-Market Session,2018-02-27 07:47:00-05:00,AKRX,neutral
55151.0,Akorn Shares Fall 30% After Hours on Fresnius Report of Akorn Breach of FDA Data Integrity,2018-02-26 16:47:00-05:00,AKRX,positive
55152.0,UPDATE: Akorn Shares Had Fallen As Much As 4.9% Earlier Following Cautious Comments From Fresenius Related To Deal With Co.,2017-11-21 11:57:00-05:00,AKRX,negative
55153.0,Akorn Shares Spike Higher Off Session Lows Amid Report Co. Spokesperson Has Said There Have Been No Changes To Deal With Fresenius,2017-11-21 11:47:00-05:00,AKRX,negative
55154.0,Akorn 8-K Filing Shows Chair John Kapoor Resigned; Alan Weinstein Named As Replacement,2017-10-31 07:12:00-04:00,AKRX,negative
55155.0,Fresenius Says Arrest Of Akorn's Kapoor Will Not Impact Deal Between Cos.,2017-10-26 12:52:00-04:00,AKRX,negative
55156.0,"John Kapoor, Founder Of Insys, Indicted On Charges Of Bribing Doctors To Overprescribe Opioids",2017-10-26 12:22:00-04:00,AKRX,negative
55157.0,"Akorn Shares Falling As John Kapoor Was Indicted For Bribery Charges, Kapoor Has A 25% Stake In Akorn",2017-10-26 11:38:00-04:00,AKRX,negative
55158.0,Akorn Reports Holders Have Approved Deal With Fresenius Kabi,2017-07-19 16:30:00-04:00,AKRX,positive
55159.0,Akorn Sells off to Low of $33.52,2017-07-19 12:23:00-04:00,AKRX,negative
55160.0,"Block Trade: Akorn 267,225 @ $33.55",2017-07-12 15:48:00-04:00,AKRX,negative
55161.0,Akorn Shares Spike ~$0.30 Higher Over Last Min,2017-06-07 10:56:00-04:00,AKRX,positive
55162.0,13D from Fresenius on Akorn Shows 24.93% Stake,2017-05-04 15:17:00-04:00,AKRX,neutral
55163.0,Watch These 8 Huge Call Purchases In Thursday Trade,2017-05-04 04:43:00-04:00,AKRX,positive
55164.0,Benzinga's Option Alert Recap From May 3,2017-05-03 16:52:00-04:00,AKRX,positive
55165.0,Option Alert: Akorn Sep 35.0 Calls Sweep: 500 @  ASK  $0.15: 500 traded vs 8564 OI:  Earnings 5/9 After Close [est]  $33.17,2017-05-03 11:25:00-04:00,AKRX,positive
55166.0,Watch These 8 Huge Call Purchases In Monday Trade,2017-05-01 04:03:00-04:00,AKRX,positive
55167.0,Benzinga's Option Alert Recap From April 28,2017-04-28 16:34:00-04:00,AKRX,positive
55168.0,Option Alert: Akorn Sep 35.0 Calls Sweep: 500 @  ASK  $0.15: 1322 traded vs 6676 OI:  Earnings 5/9 After Close [est]  $33.39 Ref,2017-04-28 12:18:00-04:00,AKRX,positive
55169.0,"Companies Holding Shareholder Meetings Today Include: Akorn, AstraZeneca, HCA Holdings, Johnson & Johnson, & Lockheed Martin",2017-04-27 08:41:00-04:00,AKRX,neutral
55170.0,5 Biggest Price Target Changes For Tuesday,2017-04-25 10:09:00-04:00,AKRX,neutral
55171.0,"Benzinga's Top Upgrades, Downgrades For April 25, 2017",2017-04-25 09:27:00-04:00,AKRX,positive
55172.0,PiperJaffray Downgrades Akorn to Neutral,2017-04-25 07:47:00-04:00,AKRX,neutral
55173.0,Jefferies Downgrades Akorn from Buy to Hold,2017-04-25 07:46:00-04:00,AKRX,neutral
55174.0,William Blair Downgrades Akorn from Outperform to Market Perform,2017-04-25 07:45:00-04:00,AKRX,neutral
55175.0,"Wall Street's M&A Chatter From April 24: Akorrn, Albertsons-Whole Foods, US Foods-FirstClass, PPG-Akzo Nobe",2017-04-25 07:28:00-04:00,AKRX,neutral
55176.0,"15 Stocks To Watch For April 25, 2017",2017-04-25 05:46:00-04:00,AKRX,neutral
55177.0,Watch These 5 Huge Put Purchases In Tuesday Trade,2017-04-25 04:51:00-04:00,AKRX,positive
55178.0,Akorn Shares to Resume Trade at 5:30 p.m. EDT,2017-04-24 17:05:00-04:00,AKRX,positive
55179.0,Fresenius Announces It Will Acquire Akorn For $34/Share,2017-04-24 16:58:00-04:00,AKRX,neutral
55180.0,Acorn Shares Halted News Pending,2017-04-24 16:25:00-04:00,AKRX,positive
55181.0,Benzinga's Option Alert Recap From April 24,2017-04-24 16:22:00-04:00,AKRX,positive
55182.0,UPDATE: Fresenius Reportedly Nearing Deal With Akorn That Values Co. At $33-$35 Per Share,2017-04-24 12:47:00-04:00,AKRX,positive
55183.0,Fresenius Nears Deal To Acquire Akorn,2017-04-24 12:42:00-04:00,AKRX,neutral
55184.0,Option Alert: Akorn Jun 30.0 Puts Sweep: 1000 @  ASK  $1.40: 1000 traded vs 478 OI:  Earnings 5/9 After Close [est]  $32.45 Ref,2017-04-24 11:30:00-04:00,AKRX,positive
55185.0,4 Stocks With Strong Technical Momentum,2017-04-21 08:40:00-04:00,AKRX,positive
55186.0,Option Alert: Akorn May 30.0 Puts Sweep: 1756 @  ASK  $1.199: 2316 traded vs 2677 OI:  Earnings 5/9 After Close [est]  $33.06 Ref,2017-04-19 14:29:00-04:00,AKRX,positive
55187.0,Akorn Shares Keep Moving Higher As Acquisition Rumored To Be 'Imminent',2017-04-19 13:58:00-04:00,AKRX,positive
55188.0,"Wall Street's M&A Chatter From April 18: Akorn, Cardinal Health, Post-Weetabix, Nivalis Therapeutics-Alpine Immune",2017-04-19 06:46:00-04:00,AKRX,positive
55189.0,Benzinga's Option Alert Recap From April 18,2017-04-18 16:19:00-04:00,AKRX,positive
55190.0,Akorn Shares Up 2.06%; Street Insider Reporting Fresenius Deal To Acquire Co. 'Imminent',2017-04-18 13:21:00-04:00,AKRX,positive
55191.0,Akorn Shares Spike To High Of $32.83,2017-04-18 13:18:00-04:00,AKRX,positive
55192.0,Option Alert: Akorn Apr 32.5 Calls Sweep: 832 @  ASK  $1.051: 1777 traded vs 1702 OI:  Earnings 5/9 After Close [est]  $32.11 Ref,2017-04-18 13:16:00-04:00,AKRX,positive
55193.0,Benzinga's Option Alert Recap From April 17,2017-04-17 16:27:00-04:00,AKRX,positive
55194.0,Option Alert: Akorn Apr 30.0 Calls: 1000 @  ASK  $2.60: 1029 traded vs 1038 OI:  Earnings 5/9 After Close [est]  $31.97 Ref,2017-04-17 13:24:00-04:00,AKRX,positive
55195.0,Watch These 8 Huge Call Purchases In Monday Trade,2017-04-17 04:32:00-04:00,AKRX,positive
55196.0,Benzinga's Option Alert Recap From April 13,2017-04-13 16:49:00-04:00,AKRX,positive
55197.0,Option Alert: Akorn May 35.0 Calls: 960 @  ASK  $0.90: 7626 traded vs 14k OI:  Earnings 5/9 After Close [est]  $32.64 Ref,2017-04-13 14:32:00-04:00,AKRX,positive
55198.0,Watch These 6 Huge Call Purchases In Thursday Trade,2017-04-13 06:40:00-04:00,AKRX,positive
55199.0,Benzinga's Option Alert Recap From April 12,2017-04-13 06:38:00-04:00,AKRX,positive
55200.0,Option Alert: Akorn May $37.5 Call; 2070 @Bid @$0.15; Ref =$32.92,2017-04-12 13:46:00-04:00,AKRX,positive
55201.0,"Analyst: Akorn Could Be Sold For As Much As $34 Per Share, But There's Double-Digits Downside If Deal Doesn't Happen",2017-04-11 14:47:00-04:00,AKRX,negative
55202.0,Akorn Take-Out Chatter Supported By Trend Of Consolidation In Generic Drug Companies,2017-04-10 09:46:00-04:00,AKRX,positive
55203.0,The Market In 5 Minutes,2017-04-10 09:15:00-04:00,AKRX,neutral
55204.0,16 Stocks Moving In Monday's Pre-Market Session,2017-04-10 08:54:00-04:00,AKRX,neutral
55205.0,"Wall Street's M&A Chatter From April 7-9: 21st Century Fox, Akorn, BioTelemetry-LifeWatch, Intrawest Resorts",2017-04-10 07:07:00-04:00,AKRX,neutral
55206.0,"6 Stocks To Watch For April 10, 2017",2017-04-10 06:48:00-04:00,AKRX,neutral
55207.0,Akorn +13.3% Premarket @$33.75; Co Confirmed Friday it was in Talks with Fresnius Regarding Potential Takeover,2017-04-10 06:27:00-04:00,AKRX,neutral
55208.0,There Was An Unusual Options Trade Prior To Akorn Takeout Chatter,2017-04-07 14:38:00-04:00,AKRX,neutral
55209.0,"Akorn Shares Have Resumed, Now Up 17.3%",2017-04-07 13:10:00-04:00,AKRX,positive
55210.0,"Teva Shares Spike Higher, Still Down ~0.4%, Following Report of Fresenius Interest in Generic Maker, Akorn",2017-04-07 13:07:00-04:00,AKRX,positive
55211.0,Hearing Fresenius Said to Consider Offer for Akorn,2017-04-07 13:06:00-04:00,AKRX,neutral
55212.0,"Endo Int'l Shares Spike Into Positive Territory, Now Up 2%, Vertex Shares Also at Session Highs Up 2.3%",2017-04-07 13:05:00-04:00,AKRX,positive
55213.0,"Akorn Shares Spike Higher, Now Up ~14%, Halted on Circuit Breaker",2017-04-07 13:04:00-04:00,AKRX,positive
55214.0,Does Reward Potential Still Outweigh The Risk In Akorn Shares?,2017-03-06 13:25:00-05:00,AKRX,positive
55215.0,15 Biggest Mid-Day Losers For Monday,2017-03-06 13:15:00-05:00,AKRX,negative
55216.0,Mid-Day Market Update: Dow Falls 80 Points; Concert Pharma Shares Spike Higher,2017-03-06 12:18:00-05:00,AKRX,positive
55217.0,10 Biggest Price Target Changes For Monday,2017-03-06 10:06:00-05:00,AKRX,neutral
55218.0,"Benzinga's Top Upgrades, Downgrades For March 6, 2017",2017-03-06 09:48:00-05:00,AKRX,positive
55219.0,"Deutsche Bank Downgrades Akorn To Hold, Lowers Price Target To $24",2017-03-06 06:15:00-05:00,AKRX,negative
55220.0,"Akorn Reports Received FDA Approval for Ephedrine Sulfate Injection, USP",2017-03-02 08:25:00-05:00,AKRX,positive
55221.0,"Akorn Sees FY17 Adj. EPS $1.53-$1.72, Adj. EBITDA $363M-$401M",2017-03-01 07:07:00-05:00,AKRX,neutral
55222.0,Akorn Sees FY17 Sales $1.01B-$1.06B vs $1.12B Est.,2017-03-01 07:07:00-05:00,AKRX,neutral
55223.0,"Acorn Reports Q4 Adj. EPS $0.58 vs $0.57 Est., Sales $284M vs $288M Est.",2017-03-01 07:07:00-05:00,AKRX,neutral
55224.0,"Earnings Scheduled For March 1, 2017",2017-03-01 05:03:00-05:00,AKRX,neutral
55225.0,Watch These 10 Huge Put Purchases In Tuesday Trade,2017-01-31 04:48:00-05:00,AKRX,positive
55226.0,Benzinga's Option Alert Recap From January 30,2017-01-30 17:15:00-05:00,AKRX,positive
55227.0,Option Alert: Akorn  Feb 17.5 Puts Sweep: 637 @  ASK  $0.50: 1436 traded vs 26 OI:  Earnings 2/23 Unspecified (est)  $18.52 Ref,2017-01-30 14:25:00-05:00,AKRX,positive
55228.0,Akorn Cracks Open A Buy Rating With Vetr,2017-01-19 16:35:00-05:00,AKRX,neutral
55229.0,18 Biggest Mid-Day Gainers For Monday,2016-12-12 12:45:00-05:00,AKRX,neutral
55230.0,Benzinga's Volume Movers,2016-12-12 10:34:00-05:00,AKRX,neutral
55231.0,"JP Morgan on Akorn: Sees 483 Remediation as a 'Clear Positive,' Mgmt Focused Should Return to Delivering an Attractive Pipeline",2016-12-12 10:00:00-05:00,AKRX,positive
55232.0,Akorn Shares Move Lower For 2nd Day In A Row; Now Down 4.96% On Heavy Volume After Closing 6.3% Lower Tuesday,2016-12-07 11:30:00-05:00,AKRX,negative
55233.0,10 Stocks With Lowest Close In Three Weeks,2016-12-07 07:07:00-05:00,AKRX,negative
55234.0,Akorn Shares Down 5+% Midday; Hearing RBC Analyst Out Cautious On The Name Citing Competition From Novartis' FDA Approved Atropine Sulfate,2016-12-06 12:39:00-05:00,AKRX,positive
55235.0,Benzinga's Top Initiations,2016-12-01 09:17:00-05:00,AKRX,positive
55236.0,"Goldman Sachs Initiates Coverage On Akorn at Sell, Announces $20.00 Target",2016-12-01 08:14:00-05:00,AKRX,neutral
55237.0,Akorn Launches Ibuprofen Oral Suspension,2016-11-29 07:34:00-05:00,AKRX,neutral
55238.0,"Akorn Reports PTAB Ruled In Favor of Co. in IPR Proceeding, Found All Claims of '319 Patent Related to Durezol Formulation Obvious",2016-11-28 17:18:00-05:00,AKRX,positive
55239.0,"Akorn Shares Up 4.7%, Deutsche Bank Upgraded Shares From Hold To Buy",2016-11-07 13:45:00-05:00,AKRX,positive
55240.0,Akorn Spikes to High of $20.68 on Volume,2016-11-07 13:43:00-05:00,AKRX,neutral
55241.0,"Wallachbeth Downgrades Akorn, Inc. - Common Stock to Hold",2016-11-07 09:22:00-05:00,AKRX,neutral
55242.0,"Bank of America Downgrades Akorn, Inc. - Common Stock to Underperform",2016-11-07 07:20:00-05:00,AKRX,neutral
55243.0,"Despite Department Of Justice Investigation, Now May Be The Time To Buy Generic Drug Stocks",2016-11-04 13:53:00-04:00,AKRX,negative
55244.0,"RBC Capital Downgrades Akorn, Inc. - Common Stock to Sector Perform",2016-11-04 06:43:00-04:00,AKRX,neutral
55245.0,"Akorn Sees FY16 Rev. $1.06-$1.08B vs. Est. $1.08B, EPS $2.10-$2.20 vs. Est. $2.15",2016-11-03 07:25:00-04:00,AKRX,neutral
55246.0,"Akorn Reports Q3 EPS $0.56 vs. Est. $0.54, Rev. $284M vs. Est. $267M",2016-11-03 07:25:00-04:00,AKRX,neutral
55247.0,Benzinga's Top Upgrades,2016-09-15 09:04:00-04:00,AKRX,positive
55248.0,"PiperJaffray Upgrades Akorn to Overweight, Raises PT to $34.00",2016-09-15 06:09:00-04:00,AKRX,negative
55249.0,Akorn Relaunches Ofloxacin Otic Solution,2016-08-25 08:31:00-04:00,AKRX,positive
55250.0,Drug Price Hike Concerns Spill Over Into Other Pharma Stocks,2016-08-24 15:24:00-04:00,AKRX,neutral
55251.0,"Teva Pharma, Acorn Shares Plunge Over Last Few Mins; Teva Now Down 3.5% for Session, Akorn Shares Are Down ~4.4%",2016-08-24 15:14:00-04:00,AKRX,positive
55252.0,Deutsche Bank Downgrades Akorn to Hold,2016-08-05 06:20:00-04:00,AKRX,neutral
55253.0,"Akorn Sees FY16 Rev. $1.06-$1.08B vs. Est. $1.08B, EPS $2.10-$2.20 vs. Est. $2.15",2016-08-04 07:18:00-04:00,AKRX,neutral
55254.0,"Akorn Reports Q2 Adj. EPS $0.58 vs. Est. $0.55, Rev. $281M vs. Est. $272.9M",2016-08-04 07:17:00-04:00,AKRX,neutral
55255.0,Benzinga's Top Downgrades,2016-08-02 09:08:00-04:00,AKRX,positive
55256.0,Raymond James Downgrades Akorn to Market Perform,2016-08-02 06:02:00-04:00,AKRX,neutral
55257.0,"Watch Potential Buyers of Generic Assets Following Report FTC Will Require Teva to Divest Generic Drugs: Valeant, Mylan, Akorn, Novartis",2016-07-27 14:35:00-04:00,AKRX,positive
55258.0,Option Alert: AKRX Sep16 35.0 Calls Sweep: 630 @  ASK  $1.75: 719 traded vs 4091 OI:  Earnings 8/4 Before Open  $33.14 Ref,2016-07-25 15:46:00-04:00,AKRX,positive
55259.0,Akorn Shares Flat Ahead of William Blair Growth Stock Conference Presentation,2016-06-15 14:17:00-04:00,AKRX,positive
55260.0,"Susquehanna Says VRX Bid From TPG/TAKEDA May Put A Floor Under ENDP, LCI, AKRX",2016-05-31 08:58:00-04:00,AKRX,neutral
55261.0,Option Alert: AKRX Jul16 25.0 Puts Sweep: 1145 @  ASK  $0.90: 1329 traded vs 21 OI: $29.98 Ref,2016-05-27 10:09:00-04:00,AKRX,positive
55262.0,"Akorn Reaffirms FY16 Adj. EPS Outlook $2.10-$2.20 vs $2.17 Est., Sales $1.06B-$1.08B vs $1.08B Est.",2016-05-16 16:44:00-04:00,AKRX,neutral
55263.0,"Akorn Reports Q1 Adj. EPS $0.54, Inline, Sales $268M vs $267.7M Est.",2016-05-16 16:43:00-04:00,AKRX,neutral
55264.0,"Earnings Scheduled For May 16, 2016",2016-05-16 04:30:00-04:00,AKRX,neutral
55265.0,"Akorn Q4 EPS $0.27 vs $0.43 est, Revenue $279.98M vs $222.64M est",2016-05-10 06:52:00-04:00,AKRX,neutral
55266.0,Akorn Reaffirms FY 2016 Guidance,2016-05-10 06:50:00-04:00,AKRX,neutral
55267.0,Akorn Announces Has Submitted Restated 2014 Financials,2016-05-10 06:49:00-04:00,AKRX,neutral
55268.0,Mid-Morning Market Update: Markets Edge Higher; Tyson Foods Tops Q2 Estimates,2016-05-09 09:55:00-04:00,AKRX,positive
55269.0,Akorn Resumes Trading,2016-05-06 14:59:00-04:00,AKRX,neutral
55270.0,"AkornSays on Monday, May 9, 2016, Company Plans to File Annual Report on Form 10-K for Year Ended December 31, 2015",2016-05-06 14:58:00-04:00,AKRX,neutral
55271.0,Akorn Halted on Circuit-Breaker,2016-05-06 14:55:00-04:00,AKRX,neutral
55272.0,Mid-Afternoon Market Update: U.S. Stocks Turn Higher; Endo International Shares Plunge,2016-05-06 14:30:00-04:00,AKRX,positive
55273.0,Option Alert: AKRX May16 22.5 Puts Sweep: 651 @  ASK  $1.09: 653 traded vs 1823 OI: $26.84 Ref,2016-04-19 09:53:00-04:00,AKRX,positive
55274.0,Option Alert: AKRX May16 30.0 Calls: 1000 @  ASK  $1.00: 1000 traded vs 177 OI: $23.29 Ref,2016-03-28 12:38:00-04:00,AKRX,positive
55275.0,"Leerink Swann Maintains Market Perform on Akorn, Raises PT to $28.00",2016-03-23 08:45:00-04:00,AKRX,neutral
55276.0,"Susquehanna Maintains Neutral on Akorn, Lowers PT to $30.00",2016-03-23 08:45:00-04:00,AKRX,negative
55277.0,"Jefferies Maintains Buy on Akorn, Lowers PT to $35.00",2016-03-23 08:18:00-04:00,AKRX,negative
55278.0,"William Blair Maintains Outperform on Akorn, Lowers PT to $36.00",2016-03-23 07:05:00-04:00,AKRX,negative
55279.0,Mid-Afternoon Market Update: US Stocks Gain; Sunedison Shares Tumble,2016-03-22 15:13:00-04:00,AKRX,positive
55280.0,Mid-Day Market Update: Mattress Firm Drops Following Weak Results; NQ Mobile Shares Surge,2016-03-22 12:05:00-04:00,AKRX,negative
55281.0,Rodman & Renshaw: Valeant Still Worth $118 Despite 'Soap Opera',2016-03-22 11:52:00-04:00,AKRX,positive
55282.0,Benzinga's Volume Movers,2016-03-22 10:15:00-04:00,AKRX,neutral
55283.0,Mid-Morning Market Update: Markets Open Lower; G-III Apparel Misses Q4 Expectations,2016-03-22 09:49:00-04:00,AKRX,negative
55284.0,"Akorn Sees FY16 EPS $2.10-$2.20 vs. Est. $2.27, Rev. $1.06-$1.08B vs. Est. $1.09B",2016-03-22 07:06:00-04:00,AKRX,neutral
55285.0,"Akorn Reports Prelim FY15 Rev. $985M vs. Est. $971M, EPS $1.93 vs. Est. $1.95",2016-03-22 07:05:00-04:00,AKRX,neutral
55286.0,Stocks Hitting 52-Week Lows,2016-03-18 10:49:00-04:00,AKRX,negative
55287.0,"Leerink Swann Maintains Market Perform on Akorn, Lowers PT to $24.00",2016-03-16 06:06:00-04:00,AKRX,negative
55288.0,Akorn Reports Received Expected Added Delinquency Notice from NASDAQ,2016-03-07 07:08:00-05:00,AKRX,neutral
55289.0,Akorn Reports Conclusion of Audit Committee Independent Investigation,2016-01-27 16:36:00-05:00,AKRX,neutral
55290.0,Option Alert: AKRX Sep16 30.0 Calls Sweep: 500 @  ASK  $6.00: 500 traded vs 0 OI: $28.40 Ref,2016-01-22 10:14:00-05:00,AKRX,positive
55291.0,Akorn Names Greg Lawless Chief HR Officer,2016-01-21 07:01:00-05:00,AKRX,neutral
55292.0,"Akorn Launches Buprenorphine/Naloxone Sublingual Tablets and Tobramycin Injection, IMS Health Sales FY15 Sales Were ~$312M",2016-01-19 07:02:00-05:00,AKRX,neutral
55293.0,"Akorn Gives Materials Updates, Receives Listing Extension From Nasdaq Through May 9th, 2016",2016-01-14 17:25:00-05:00,AKRX,neutral
55294.0,Option Alert: AKRX Jan16 35.0 Puts Sweep: 1046 @  Above Ask!  $0.44: 1046 traded vs 249 OI: $37.60 Ref,2016-01-08 15:29:00-05:00,AKRX,positive
55295.0,Piper Jaffray: Akorn's Stock Will Be Delisted In 2016,2015-12-18 11:18:00-05:00,AKRX,neutral
55296.0,Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016,2015-12-18 10:52:00-05:00,AKRX,neutral
55297.0,Akorn Volatility Being Attributed To Sachem's Bullish Commentary,2015-11-16 10:11:00-05:00,AKRX,neutral
55298.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio,2015-10-27 04:23:00-04:00,AKRX,negative
55299.0,Akorn Gives Update on Alternative Fulfillment Systems,2015-10-21 15:10:00-04:00,AKRX,neutral
55300.0,"Biotech Names Like Horizon, Pacira, Akorn, Shire, Mallinckrodt  Volatile On Citron Report & Subsequent Valeant Pharma. Press Release",2015-10-21 14:14:00-04:00,AKRX,positive
55301.0,Akorn Appoints Duane A. Portwood as CFO,2015-10-13 17:01:00-04:00,AKRX,neutral
55302.0,Option Alert: $AKRX Dec $35 Call; 3300 Contracts @Ask @$1.80,2015-10-02 14:23:00-04:00,AKRX,positive
55303.0,Akorn Launches Doxercalciferol Injection,2015-09-21 07:01:00-04:00,AKRX,neutral
55304.0,"Apricus Reports Top-Line Phase 2a Data for RayVa(TM), Its Topical Treatment for Raynaud's Phenomenon",2015-09-17 07:00:00-04:00,AKRX,neutral
55305.0,The Coming Drug-Patent Cliff Is Pushing This Portfolio Up,2015-08-20 14:48:00-04:00,AKRX,neutral
55306.0,Akorn Names Randy Pollard CFO,2015-08-04 16:35:00-04:00,AKRX,neutral
55307.0,ETFs For The Next Pharma Takeover Candidates,2015-07-28 13:08:00-04:00,AKRX,neutral
55308.0,5 Mid-Caps With Unsustainable Cash Burn Rates,2015-07-27 09:23:00-04:00,AKRX,neutral
55309.0,"Pharma Pair Trade? Susquehanna Starts Lannet At Buy, Akorn At Neutral",2015-07-21 11:31:00-04:00,AKRX,neutral
55310.0,"Susquehanna Initiates Coverage on Akorn at Neutral, Announces $48.00 PT",2015-07-21 07:25:00-04:00,AKRX,neutral
55311.0,"Susquehanna Initiates Coverage on Akorn at Neutral, Announces $48.00 PT",2015-07-20 16:45:00-04:00,AKRX,neutral
55312.0,Akorn Announces Launch of Acetylcysteine Injection,2015-07-08 07:06:00-04:00,AKRX,neutral
55313.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest EPS Growth Forecast For Next 5 Years,2015-06-19 04:43:00-04:00,AKRX,positive
55314.0,Analyst Knocks High-Profile Biotech Merger Battle; Opportunities Elsewhere,2015-06-03 17:05:00-04:00,AKRX,neutral
55315.0,"Raymond James Initiates Coverage on Akorn at Outperform, Announces $53.00 PT",2015-06-03 06:32:00-04:00,AKRX,neutral
55316.0,Who's The Next Big Pharma Acquisition?,2015-05-29 11:20:00-04:00,AKRX,neutral
55317.0,Akorn Earlier Announced Co. Received NASDAQ Delinquency Notice: Co. Was Not In Compliance Following Failed Filing of 10-Q by May 11th,2015-05-18 07:13:00-04:00,AKRX,negative
55318.0,Akorn 10-K Restates Financial ANd Doesn't Expect To Extend Reporting Period,2015-05-08 16:11:00-04:00,AKRX,negative
55319.0,Morning Market Losers,2015-04-27 09:53:00-04:00,AKRX,negative
55320.0,Benzinga's Top #PreMarket Losers,2015-04-27 08:08:00-04:00,AKRX,negative
55321.0,"Akorn Shares Fall 15% Premarket Following Report of Overstatement of Revenue, Downgrade",2015-04-27 07:34:00-04:00,AKRX,neutral
55322.0,Piper Jaffray Downgrades Akorn to Neutral,2015-04-27 06:36:00-04:00,AKRX,neutral
55323.0,"After-Hours Movers Friday: Akorn Inc., Weight Watchers International Inc.",2015-04-25 11:35:00-04:00,AKRX,neutral
55324.0,Akorn Trading Resumed,2015-04-24 16:30:00-04:00,AKRX,neutral
55325.0,"Akorn Cites Overstatement Of Revenue, Pre-Tax Income From $20M To $35M For Year Ending 2014; Affirms 2015 Guidance",2015-04-24 16:08:00-04:00,AKRX,negative
55326.0,Akorn Trading Halted; News Pending,2015-04-24 16:01:00-04:00,AKRX,neutral
55327.0,Alert: JP Morgan Just Started Akorn At Overweight,2015-04-15 07:32:00-04:00,AKRX,positive
55328.0,"JP Morgan Initiates Coverage on Akorn at Overweight, Announces $61.00 PT",2015-04-15 04:04:00-04:00,AKRX,neutral
55329.0,"Akorn Initiated At Deutsche Bank, Notes Impressive Drug Pipeline",2015-04-08 09:43:00-04:00,AKRX,positive
55330.0,"Deutsche Bank Initiates Coverage on Akorn at Buy, Announces $55.00 PT",2015-04-07 14:27:00-04:00,AKRX,neutral
55331.0,"Avondale Partners Initiates Coverage on Akorn at Outperform, Announces $56.00 PT",2015-03-27 10:27:00-04:00,AKRX,neutral
55332.0,Akorn Launches Phenylephrine HCl Ophthalmic Solution,2015-03-20 07:02:00-04:00,AKRX,positive
55333.0,Morning Market Gainers,2015-03-18 09:43:00-04:00,AKRX,neutral
55334.0,Benzinga's Top #PreMarket Gainers,2015-03-18 08:07:00-04:00,AKRX,positive
55335.0,"Tuesday's After-Hours Movers: Oracle, Papa Murphy's And More",2015-03-17 20:31:00-04:00,AKRX,neutral
55336.0,"Friday's After-Hours Movers: Akorn, Rosetta Resources And More",2015-03-13 17:42:00-04:00,AKRX,neutral
55337.0,Morning Market Gainers,2015-03-11 09:39:00-04:00,AKRX,neutral
55338.0,Benzinga's Top #PreMarket Gainers,2015-03-11 08:08:00-04:00,AKRX,positive
55339.0,"Akorn Offers Update on Recent Product Lines: Unveils AP-Rated Generic of Astella's Adenoscan, Hospira's Precedex Injection, AbbVie's Marinol Caps, Re-Launching Sulfamethoxazole, Trimethoprim",2015-03-11 07:04:00-04:00,AKRX,neutral
55340.0,Morning Market Losers,2015-03-10 09:50:00-04:00,AKRX,negative
55341.0,"Akorn Reiterates 2015 Revenue Between $960-$980M, Adj. EPS $1.88-$1.98",2015-03-10 09:10:00-04:00,AKRX,neutral
55342.0,Benzinga's Top #PreMarket Losers,2015-03-10 08:16:00-04:00,AKRX,negative
55343.0,Akorn Announces Comprehensive Policy to Support Use of Its Products to Promote Human Health,2015-03-04 07:02:00-05:00,AKRX,positive
55344.0,"Akorn CEO Rai Buys 5,000 Shares @$47.70/Share -Form 4",2015-03-03 16:22:00-05:00,AKRX,positive
55345.0,"Monday's After-Hours Movers: Ocwen Financial, NutriSystem And McDermott International Lead The Pack",2015-03-02 19:15:00-05:00,AKRX,neutral
55346.0,Needham Downgrades Akorn to Hold,2015-02-27 05:22:00-05:00,AKRX,neutral
55347.0,"Akorn Q4 EPS $0.50 vs $0.45 est, Revenue $227.8M vs $219M est",2015-02-26 07:13:00-05:00,AKRX,neutral
55348.0,"Earnings Scheduled For February 26, 2015",2015-02-26 05:00:00-05:00,AKRX,neutral
55349.0,"Standard & Poor's Announces Akorn to Replace Protective Life in S&P MidCap 400, ANI Pharma to Replace Gentiva, United Insurance to Replace Akorn in SmallCap 600",2015-01-27 17:32:00-05:00,AKRX,positive
55350.0,"Jefferies Weighs In On Specialty Pharmaceuticals After Management Meetings, Raises Price Targets On 5 Stocks",2015-01-20 13:00:00-05:00,AKRX,neutral
55351.0,US Stock Futures Surge Ahead Of Earnings,2015-01-20 07:16:00-05:00,AKRX,neutral
55352.0,"Akorn Reports FDA Approval for Phenylephrine HCL Ophthalmic Solution, Will Re-Launch Product 'Shortly'",2015-01-20 07:05:00-05:00,AKRX,positive
55353.0,Akorn Receives FDA Approval for Phenylephrine HCl Ophthalmic Solution,2015-01-20 07:01:00-05:00,AKRX,positive
55354.0,Akorn Files Abbreviated New Drug Application With FDA For Approval to Market difluprednate ophthalmic emulsion,2015-01-15 17:32:00-05:00,AKRX,positive
55355.0,Hybio Pharmaceutical Signs Strategic Cooperation Agreement with Akorn,2015-01-06 06:18:00-05:00,AKRX,positive
55356.0,Top 4 NASDAQ Stocks In The Drugs Generic Industry With The Highest EPS Growth Forecast For Next 5 Years,2014-12-29 04:33:00-05:00,AKRX,positive
55357.0,16 Stocks 2 Experts Are Watching This Week,2014-12-23 09:42:00-05:00,AKRX,neutral
55358.0,UPDATE: CRT Capital Upgrades Akorn,2014-11-14 13:00:00-05:00,AKRX,neutral
55359.0,Akorn Shares Continue Higher as CRT Earlier Upgraded to Buy,2014-11-14 12:43:00-05:00,AKRX,positive
55360.0,"Akorn, Inc. Sees Q4 EPS $0.44-0.46 vs $0.38 Est; Sees Sales $215.0M-225.0M",2014-11-06 07:33:00-05:00,AKRX,neutral
55361.0,"Akorn, Inc. Sees Q3 EPS $0.27 vs $0.25 Est; Sees Sales $132.70M",2014-11-06 07:33:00-05:00,AKRX,neutral
55362.0,Meet The 5 Companies Loving Obamacare,2014-11-04 20:04:00-05:00,AKRX,positive
55363.0,"Wallachbeth Capital Initiates Coverage on Akorn, Inc. at Buy, Announces $43.00 PT",2014-10-14 06:32:00-04:00,AKRX,neutral
55364.0,UPDATE: Akorn Expecting Deal with Xopenex to Add $0.07-$0.08 to FY15 Adj. EPS,2014-09-30 16:17:00-04:00,AKRX,neutral
55365.0,Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion For $45M,2014-09-30 16:16:00-04:00,AKRX,positive
55366.0,"RBC Capital Upgrades Akorn, Inc. to Outperform, Raises PT to $45.00",2014-09-29 05:51:00-04:00,AKRX,neutral
55367.0,"Is Akorn, Inc. An Easy Buy This Week?",2014-09-16 20:17:00-04:00,AKRX,positive
55368.0,Shares of Acorn Spike Higher Following Reuters Headline Co. is Exploring Possible Offer for UCB SA US Unit,2014-09-11 13:01:00-04:00,AKRX,positive
55369.0,Akorn Unit Hi-Tech's Gatifloxacin Approved By FDA,2014-09-04 13:09:00-04:00,AKRX,positive
55370.0,Akorn Reports Q2 Adjusted EPS of $0.25 vs $0.20 Est; Revenue of $150.70M vs $145.16M Est,2014-08-05 06:05:00-04:00,AKRX,neutral
55371.0,"FTC Places Conditions on Akron's Proposed Deal of Versapharma, Co. Will Need to Sell Rights to Generic Rifampin",2014-08-04 15:34:00-04:00,AKRX,neutral
55372.0,5 Drug Companies Profiting From Generics,2014-08-04 08:29:00-04:00,AKRX,positive
55373.0,"Option Alert: Akorn Sep $40 Call; 1,800 Contracts Traded vs 0 OI; Currently $34.24",2014-07-02 12:58:00-04:00,AKRX,positive
55374.0,Akorn Shares Rally Following Increased Price Target,2014-07-01 12:49:00-04:00,AKRX,positive
55375.0,Benzinga's Volume Movers,2014-07-01 10:28:00-04:00,AKRX,neutral
55376.0,Stocks Hitting 52-Week Highs,2014-06-30 10:16:00-04:00,AKRX,neutral
55377.0,Akorn Shares Gaining On $41 Million Sale Of Branded Drugs Unit To Valeant,2014-06-20 12:23:00-04:00,AKRX,positive
55378.0,FTC Gives Approval to Final Order Settling Charges on Akorn Purchase of Hi-Tech,2014-06-20 11:26:00-04:00,AKRX,positive
55379.0,"Akorn Reports Divestment of ECR Pharma to Valeant, Consideration $41M in Cash, Certain Liabilities",2014-06-20 11:14:00-04:00,AKRX,positive
55380.0,UPDATE: Bank Of America Reiterates On Akorn As Diverse Niche Player,2014-06-05 07:53:00-04:00,AKRX,neutral
55381.0,"Goldman Sachs Initiates Coverage on Akorn, Inc. at Neutral, Announces $27.00 PT",2014-06-02 06:31:00-04:00,AKRX,neutral
55382.0,Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest ROA,2014-05-13 04:27:00-04:00,AKRX,positive
55383.0,Benzinga's Weekend M&A Chatter,2014-05-11 22:28:00-04:00,AKRX,neutral
55384.0,Shares of Akorn Up ~3.5% Upon Resumption,2014-05-09 09:51:00-04:00,AKRX,positive
55385.0,Shares of Akorn to Resume Trade at 9:50AM EDT,2014-05-09 09:45:00-04:00,AKRX,positive
55386.0,Shares of Akorn to Resume Trade at 9:50AM EDT,2014-05-09 09:45:00-04:00,AKRX,positive
55387.0,"UPDATE: Akron Expecting Deal to Add $0.10-0.12 in EPS, Sees Deal Adding $90-$100M in Annual Sales",2014-05-09 09:21:00-04:00,AKRX,neutral
55388.0,UPDATE: Akorn Acquires VersaPharm For $440M,2014-05-09 09:20:00-04:00,AKRX,neutral
55389.0,"Shares of Akorn Were Halted Following Release of Acquisition News, Code is 'News Disseminated'",2014-05-09 09:20:00-04:00,AKRX,positive
55390.0,Akorn Acquires VersaPharm For $440M,2014-05-09 09:19:00-04:00,AKRX,neutral
55391.0,"Akorn, Inc. Raises FY2014 EPS Guidance from $0.76-0.79 to $0.79-0.82 vs $0.82 Est",2014-05-06 07:06:00-04:00,AKRX,neutral
55392.0,"Akorn, Inc. Reports Q1 EPS of $0.16 vs $0.15 Est; Revenue of $90.60M vs $91.44M Est",2014-05-06 07:05:00-04:00,AKRX,neutral
55393.0,"Jefferies Initiates Coverage on Akorn, Inc. at Buy, Announces $28.00 PT",2014-04-21 16:25:00-04:00,AKRX,neutral
55394.0,Mid-Afternoon Market Update: Ukrainian Crisis Still Weighs on Select Equities as Plug Power Rallies on Cowen Note,2014-03-03 15:30:00-05:00,AKRX,negative
55395.0,Mid-Day Market Update: Akorn Shares Slip After Downbeat Outlook; Dendreon Gains,2014-03-03 12:39:00-05:00,AKRX,positive
55396.0,"Morning Losers for Mar. 3, 2014: YNDX, CETV, AKRX, CPST, LIVE",2014-03-03 10:43:00-05:00,AKRX,negative
55397.0,Mid-Morning Market Update: Markets Open Lower; Tyco To Sell South Korean Security Business For $1.93B,2014-03-03 10:30:00-05:00,AKRX,positive
55398.0,Morning Market Losers ,2014-03-03 10:23:00-05:00,AKRX,negative
55399.0,"Akorn Reports Q4 EPS of $0.14, Inline; Revenue of $85.0M vs $83.37M Est",2014-03-03 06:01:00-05:00,AKRX,neutral
55400.0,"Earnings Scheduled For March 3, 2014",2014-03-03 04:42:00-05:00,AKRX,neutral
55401.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE,2014-02-21 04:35:00-05:00,AKRX,positive
55402.0,"FDA Approvals And Changes For The Week Ending February 14, 2014",2014-02-18 16:17:00-05:00,AKRX,neutral
55403.0,Akorn Spikes Lower,2014-01-21 11:09:00-05:00,AKRX,negative
55404.0,Akorn Acquires Betimol® from Santen ,2014-01-09 13:41:00-05:00,AKRX,neutral
55405.0,Akorn Announces Purchase of Betimol from Santen; Sees Deal Adding $0.03-0.04/Share to Adj. EPS in 2014,2014-01-09 13:40:00-05:00,AKRX,neutral
55406.0,"RBC Capital Initiates Coverage on Akorn, Inc. at Sector Perform, Announces $27.00 PT",2014-01-06 17:19:00-05:00,AKRX,neutral
55407.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest Operating Margin,2013-12-16 04:26:00-05:00,AKRX,positive
55408.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest ROA,2013-12-13 04:12:00-05:00,AKRX,positive
55409.0,"Akorn Buys Three Brand Ophthalmic Products from Merck, for $52.8M, Deal Expected to Add $0.09-0.11 to 2014 Adj. EPS",2013-11-15 09:01:00-05:00,AKRX,neutral
55410.0,Akorn Reports Q3 non-GAAP EPS of $0.15 vs $0.14 Est; Revenue of $81.90M vs $80.19M Est,2013-11-05 06:26:00-05:00,AKRX,neutral
55411.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest Cash,2013-10-08 04:45:00-04:00,AKRX,positive
55412.0,"Guggenheim Securities Initiates Coverage on Akorn, Inc. at Buy, Announces $22.00 PT",2013-09-26 08:26:00-04:00,AKRX,positive
55413.0,UPDATE: Bank of America Raises PT on Akorn Following Hi-Tech Acquisition Announcement,2013-08-29 10:34:00-04:00,AKRX,neutral
55414.0,"Deutsche Bank Maintains Hold on Akorn, Inc., Raises PT to $19.00",2013-08-28 12:30:00-04:00,AKRX,neutral
55415.0,Mid-Afternoon Market Update: DSW Rises as the NASDAQ Gets Crushed,2013-08-27 15:37:00-04:00,AKRX,negative
55416.0,Mid-Day Market Update: Hi-Tech Pharmacal Rises On Acquisition News; Sanderson Farms Shares Fall,2013-08-27 13:03:00-04:00,AKRX,positive
55417.0,Mid-Morning Market Update: Markets Go Red; Tiffany Q2 Net Profit Surges 16%,2013-08-27 11:04:00-04:00,AKRX,positive
55418.0,Morning Market Movers ,2013-08-27 10:16:00-04:00,AKRX,neutral
55419.0,"Akorn to Acquire Hi-Tech Pharmacal for $640M in Cash, $43.50/Share",2013-08-27 07:02:00-04:00,AKRX,neutral
55420.0,Akorn Shares Pull Back; Hearing May Be Attributed to Approval of Competing Drug,2013-08-20 15:43:00-04:00,AKRX,positive
55421.0,"Gabelli & Co. Upgrades Akorn, Inc. to Buy",2013-08-15 08:56:00-04:00,AKRX,neutral
55422.0,"Akorn, Inc. Reports Q2 EPS of $0.14 vs $0.13 Est; Revenue of $77.0M vs $75.06M Est",2013-08-06 07:18:00-04:00,AKRX,neutral
55423.0,Top 4 Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio,2013-07-26 04:17:00-04:00,AKRX,negative
55424.0,"Mid-Day Market Update: Fossil Gains On Q1 Results, Aruba Networks Falls",2013-05-07 12:22:00-04:00,AKRX,positive
55425.0,"Mid-Morning Market Update: Markets Surge, Emerson Electric Lowers View",2013-05-07 10:56:00-04:00,AKRX,negative
55426.0,"CORRECTION: Akorn, Inc. Reports Q1 EPS of $0.13 vs $0.14 Est; Revenue of $73.85M vs $74.07M Est",2013-05-07 06:16:00-04:00,AKRX,neutral
55427.0,"Akorn, Inc. Reports Q1 EPS of $0.13 vs $0.14 Est; Revenue of $83.35M vs $74.07M Est",2013-05-07 06:14:00-04:00,AKRX,neutral
55428.0,"Stocks to Watch for April 16, 2013",2013-04-16 09:25:00-04:00,AKRX,neutral
55429.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin,2013-03-15 04:56:00-04:00,AKRX,positive
55430.0,"Akorn, Inc. Reports Q4 EPS of $0.13 vs $0.12 Est; Revenue of $71.50M vs $69.40M Est",2013-02-26 07:07:00-05:00,AKRX,neutral
55431.0,"RBC Capital Initiated Coverage on Akorn, Inc. at Sector Perform, Announced $14.00 PT",2013-01-28 10:37:00-05:00,AKRX,neutral
55432.0,"Akorn Reaffirms FY12 Outlook; Sees FY13 Sales $325-335M vs $330M Est, EPS $0.57-0.61 vs $0.66 Est",2013-01-17 14:31:00-05:00,AKRX,neutral
55433.0,Akorn Spikes Lower,2013-01-17 14:31:00-05:00,AKRX,negative
55434.0,"Deutsche Bank Maintains Hold on Akorn, Inc., Raises PT to $14.00",2013-01-14 08:24:00-05:00,AKRX,neutral
55435.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash,2013-01-07 03:17:00-05:00,AKRX,positive
55436.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE,2012-11-29 03:19:00-05:00,AKRX,positive
55437.0,"Stocks To Watch For November 08, 2012",2012-11-08 09:25:00-05:00,AKRX,neutral
55438.0,"UPDATE: Deutsche Bank Reiterates Hold Rating, Lowers PT on Akorn",2012-11-07 11:16:00-05:00,AKRX,negative
55439.0,"Deutsche Bank Maintains Akorn at Hold, Lowers PT from $14 to $13",2012-11-07 07:12:00-05:00,AKRX,negative
55440.0,"Bank of America Maintains Akorn at Buy, Lowers PT from $18 to $17",2012-11-06 15:52:00-05:00,AKRX,negative
55441.0,From Earlier: Akorn Reports Q3 EPS $0.14 vs $0.13 Est; Revenues $69.6M vs $68.85M Est,2012-11-06 09:02:00-05:00,AKRX,neutral
55442.0,A Peek Into The Market Before The Trading Starts,2012-10-24 07:19:00-04:00,AKRX,neutral
55443.0,Akorn Announces Approval of Generic Prometrium,2012-10-24 06:22:00-04:00,AKRX,positive
55444.0,Leerink Swann Initiated Coverage on Akorn at Outperform,2012-09-27 09:10:00-04:00,AKRX,neutral
55445.0,Benzinga's Top Initiations,2012-09-26 07:36:00-04:00,AKRX,positive
55446.0,"UPDATE: Bank of America Initiates Akorn at Buy on Product, Revenue Mix  ",2012-09-26 06:36:00-04:00,AKRX,neutral
55447.0,"Bank of America Initiates Coverage on Akorn at Buy, Announces PO of $18",2012-09-26 05:51:00-04:00,AKRX,negative
55448.0,Akorn's Chairman Adopts 10b5-1 Trading Plan  ,2012-09-24 11:36:00-04:00,AKRX,positive
55449.0,Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest ROA,2012-09-04 04:03:00-04:00,AKRX,positive
55450.0,"Piper Jaffray Reiterates Overweight Rating, $21 PT on Akorn",2012-08-27 11:30:00-04:00,AKRX,negative
55451.0,"Akorn Guides FY EPS $0.50-0.52, Had Seen $0.44-0.46; Guides FY Revenue $248-258M, Had Seen $228-238M",2012-08-07 07:18:00-04:00,AKRX,neutral
55452.0,Akorn Reports Q2 EPS $0.10 vs $0.12 Est; Revenues $63.3M vs $60.55M Est,2012-08-07 07:16:00-04:00,AKRX,neutral
55453.0,Akorn Announces New Management Appointments   ,2012-08-07 07:08:00-04:00,AKRX,neutral
55454.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Revenue,2012-08-07 04:43:00-04:00,AKRX,positive
55455.0,"Deutsche Bank Downgrades Akorn from Buy to Hold, Lowers PT from $15 to $14",2012-07-23 05:44:00-04:00,AKRX,negative
55456.0,Gabelli & Company Initiates Akorn at Hold,2012-07-19 09:16:00-04:00,AKRX,neutral
55457.0,"Piper Jaffray Maintains Akorn at Overweight, Raises PT from $16 to $21",2012-07-09 08:51:00-04:00,AKRX,negative
55458.0,Charts on Watch for Wednesday June 06,2012-06-05 17:20:00-04:00,AKRX,neutral
55459.0,"Wednesday's Stocks To Watch, May 23 2012",2012-05-22 17:15:00-04:00,AKRX,neutral
55460.0,Akorn Reports Q1 EPS $0.13 vs $0.11 Est; Revenues $51.7M vs $48.79M Est,2012-05-08 07:05:00-04:00,AKRX,neutral
55461.0,Earnings Scheduled For May 8,2012-05-08 00:31:00-04:00,AKRX,neutral
55462.0,FDA Denies ViroPharma's Vancocin Petition,2012-04-10 11:17:00-04:00,AKRX,negative
55463.0,ViroPharma Provides Update on Status of Citizen Petition Regarding Bioequivalence and Exclusivity for Vancocin Capsules ,2012-04-10 08:15:00-04:00,AKRX,neutral
55464.0,Benzinga's Top Pre-Market Gainers,2012-04-10 08:13:00-04:00,AKRX,positive
55465.0,A Peek Into The Market Before The Trading Starts,2012-04-10 07:18:00-04:00,AKRX,neutral
55466.0,Akorn Announces the Approval and Launch of Generic Vancocin,2012-04-10 06:37:00-04:00,AKRX,positive
55467.0,Weekly Traders Homework: Positive Jobs Report Gives Bullish Sentiment (w/ Economic Calendar and Stock Radar),2012-03-12 00:40:00-04:00,AKRX,positive
55468.0,Earnings Roundup,2012-03-06 08:31:00-05:00,AKRX,neutral
55469.0,Benzinga's Top Pre-Market Gainers,2012-03-06 08:13:00-05:00,AKRX,positive
55470.0,Akorn Reports Q4 EPS $0.11 vs $0.09 Est; Revenues $42.6M vs $38.54M Est,2012-03-06 07:03:00-05:00,AKRX,neutral
55471.0,Piper Jaffray Remains Bullish on Akorn Shares,2012-03-05 07:34:00-05:00,AKRX,positive
55472.0,UPDATE: Deutsche Bank Raises PT to $15 on Akorn,2012-02-23 07:02:00-05:00,AKRX,neutral
55473.0,Weekly Traders Homework: Contrarian Indicators Flashing (w/ Economic Calendar and Stock Radar),2012-02-20 23:47:00-05:00,AKRX,neutral
55474.0,Akorn Hits 52-Week High of $12.65,2012-02-13 09:32:00-05:00,AKRX,neutral
55475.0,Weekly Traders Homework: The First Sign Of Weakness In 2012,2012-02-12 22:52:00-05:00,AKRX,negative
55476.0,Five Interesting charts to watch next week,2012-02-11 07:36:00-05:00,AKRX,positive
55477.0,Akorn Hits 52-Week High of $12.32,2012-02-10 09:30:00-05:00,AKRX,neutral
55478.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Operating Margin,2012-02-06 04:07:00-05:00,AKRX,positive
55479.0,Akorn Hits 52-Week High of $11.98,2012-02-03 10:54:00-05:00,AKRX,neutral
55480.0,Akorn Hits 52-Week High of $11.77,2012-02-01 09:44:00-05:00,AKRX,neutral
55481.0,Notable Put Options Activity in Akorn,2012-01-20 15:08:00-05:00,AKRX,neutral
55482.0,Piper Jaffray Says Akorn's 2012 Guidance Leaves Room for Upside,2012-01-18 08:53:00-05:00,AKRX,neutral
55483.0,"Financial Breakfast: Morning News Summary for January 17, 2012",2012-01-17 07:28:00-05:00,AKRX,neutral
55484.0,Akorn Sees 2012 Adjusted EPS of $0.42 – 0.45 vs $0.45 Est; Revenues $210–220M vs $221.13M Est,2012-01-17 07:05:00-05:00,AKRX,neutral
55485.0,"End-of-Day Market Summary for December 23, 2011",2011-12-23 16:18:00-05:00,AKRX,neutral
55486.0,Hearing Akorn Recent Weakness Attributed to FDA Inspection Letter,2011-12-23 11:05:00-05:00,AKRX,negative
55487.0,"UPDATE: Deutsche Bank Maintains Buy on Akorn, Ups Target to $13",2011-12-23 08:28:00-05:00,AKRX,neutral
55488.0,"UPDATE: Piper Jaffray Maintains Overweight, Raises PT to $14 on Akorn",2011-12-23 07:40:00-05:00,AKRX,negative
55489.0,Piper Jaffray Raises PT on Akorn to $14,2011-12-23 06:01:00-05:00,AKRX,neutral
55490.0,Akorn Hits 52-Week High of $11.40,2011-12-22 13:56:00-05:00,AKRX,neutral
55491.0,Akorn Acquires Three Hospital-Based Branded Injectables from Lundbeck; Expected To Add Approximately $30-$35M in 2012,2011-12-22 13:30:00-05:00,AKRX,neutral
55492.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin,2011-12-22 03:58:00-05:00,AKRX,positive
55493.0,Akorn Hits 52-Week High of $11.15,2011-12-19 10:11:00-05:00,AKRX,neutral
55494.0,"Piper Jaffray Maintains Overweight, $12 Target on Akorn ",2011-12-15 09:52:00-05:00,AKRX,negative
55495.0,Deutsche Bank Maintains Buy Rating on Akorn,2011-12-15 09:23:00-05:00,AKRX,neutral
55496.0,Weekly Homework: In Search Of The Santa Claus Rally (w/ Economic Calendar & Stock Radar),2011-12-11 23:22:00-05:00,AKRX,neutral
55497.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash,2011-12-09 04:19:00-05:00,AKRX,positive
55498.0,Akorn Hits 52-Week High of $11.00,2011-12-05 11:31:00-05:00,AKRX,neutral
55499.0,Akorn Hits 52-Week High of $10.95,2011-12-02 09:36:00-05:00,AKRX,neutral
55500.0,Akorn Hits 52-Week High of $10.86,2011-12-01 09:53:00-05:00,AKRX,neutral
55501.0,Piper Jaffray Maintains Overweight Rating and $12 PT on Akorn,2011-12-01 07:05:00-05:00,AKRX,negative
55502.0,Akorn Hits 52-Week High of $10.64,2011-11-30 09:30:00-05:00,AKRX,neutral
55503.0,Akorn Hits 52-Week High of $10.36,2011-11-29 15:15:00-05:00,AKRX,neutral
55504.0,"Piper Jaffray Maintains Overweight, PT of $12 on Akorn ",2011-11-16 08:45:00-05:00,AKRX,negative
55505.0,"Akorn Hits New 52-Week High, $9.75",2011-11-01 09:58:00-04:00,AKRX,neutral
55506.0,Akorn Reports Q3 EPS $0.13 vs $0.07 Est; Revenues $36.7M vs $33.10M Est				,2011-11-01 07:13:00-04:00,AKRX,neutral
55507.0,"Allergan Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-25 18:02:00-04:00,AKRX,neutral
55508.0,Piper Jaffray Maintains Overweight Rating and $11 PT on Akorn,2011-10-12 08:20:00-04:00,AKRX,negative
55509.0,Deutsche Bank Reports Earnings on Specialty Pharmaceuticals,2011-10-11 09:37:00-04:00,AKRX,neutral
55510.0,UPDATE: Piper Jaffray Raising Price Target on Akorn,2011-09-19 07:36:00-04:00,AKRX,neutral
55511.0,Piper Jaffray Raises PT on Akorn to $11,2011-09-19 06:08:00-04:00,AKRX,neutral
55512.0,Stocks to Watch This Week,2011-09-18 20:45:00-04:00,AKRX,neutral
55513.0,Deutsche Bank Initiates Coverage On Akorn With Buy Rating,2011-09-16 08:06:00-04:00,AKRX,neutral
55514.0,Deutsche Bank Coverage Initiations 9/16/2011,2011-09-16 06:03:00-04:00,AKRX,neutral
55515.0,Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest Operating Margin,2011-09-06 03:42:00-04:00,AKRX,positive
55516.0,Piper Jaffray Overweight On Akorn,2011-08-03 07:42:00-04:00,AKRX,negative
55517.0,Stocks to Watch for Wednesday 8/03/2011: Fresh 52 Week Highs and Lows,2011-08-03 01:05:00-04:00,AKRX,positive
55518.0,Akorn to Acquire a Minority Stake in Aciex Therapeutics  ,2011-08-02 07:23:00-04:00,AKRX,neutral
55519.0,Earnings Scheduled For August 2,2011-08-02 03:46:00-04:00,AKRX,neutral
55520.0,"Earnings Preview: Allergan's EPS, Revenue Expected to Rise",2011-07-29 10:05:00-04:00,AKRX,neutral
55521.0,Piper Jaffray Comments on Akorn Inc After Meeting With Top Management,2011-07-22 09:31:00-04:00,AKRX,positive
55522.0,Stocks to Watch for Thursday 7/14/2011: Fresh 52 Week Highs and Lows,2011-07-14 02:29:00-04:00,AKRX,positive
55523.0,FDA Approves First Generic Versions Of The Antibiotic Levofloxacin To Treat Certain Infections,2011-06-20 15:42:00-04:00,AKRX,positive
55524.0,UPDATE: Piper Jaffray Color on Akorn Initiation,2011-06-06 07:42:00-04:00,AKRX,neutral
55525.0,"Piper Jaffray Initiates Akorn At Overweight, $10 PT",2011-06-06 06:06:00-04:00,AKRX,negative
55526.0,Akorn Announces Pricing of $100 Million of Convertible Senior Notes Due 2016 ,2011-05-26 07:33:00-04:00,AKRX,neutral
55527.0,Akorn Announces Pricing of $100 Million of Convertible Senior Notes Due 2016   ,2011-05-26 07:30:00-04:00,AKRX,neutral
55528.0,Benzinga's Top Pre-Market NASDAQ Losers,2011-05-25 08:17:00-04:00,AKRX,negative
55529.0,Akorn Announces Proposed Offering of $100 Million of Convertible Senior Notes Due 2016   ,2011-05-25 07:32:00-04:00,AKRX,neutral
55530.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest ROE,2011-05-19 01:31:00-04:00,AKRX,positive
55531.0,"Stock Picks for Wednesday May 18, 2011",2011-05-17 17:03:00-04:00,AKRX,neutral
55532.0,"Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest Revenue (PRX, CPD, HITK, AKRX)",2011-05-04 05:17:00-04:00,AKRX,positive
55533.0,Akorn Enters Into an Agreement to Acquire Advanced Vision Research for $26M in Cash (AKRX),2011-05-03 07:36:00-04:00,AKRX,positive
55534.0,"Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Highest Revenue (PRX, CPD, HITK, AKRX)",2011-03-31 00:41:00-04:00,AKRX,positive
55535.0,Akorn Reports Q4 EPS of $0.23,2011-03-01 07:31:00-05:00,AKRX,neutral
55536.0,"Earnings Scheduled For March 1 (MDR, PAY, FDP, TIVO, AKRX, HOV, BGFV, AZO, CAP, BGS, BYD, DY)",2011-03-01 03:20:00-05:00,AKRX,negative
55537.0,"Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash (MYL, SLXP, HITK, AKRX)",2011-02-17 03:11:00-05:00,AKRX,positive
55538.0,East West Bancorp: Premarket Trading,2010-12-30 07:31:00-05:00,AKRX,neutral
55539.0,Akron Making 52-Week Highs,2010-12-16 11:03:00-05:00,AKRX,neutral
55540.0,"Akorn, Inc Shares Hit 52-Week High, Up 12.2% (AKRX)",2010-12-15 13:00:00-05:00,AKRX,positive
55541.0,Akorn Trading Substantially Higher Today,2010-12-15 10:12:00-05:00,AKRX,neutral
55542.0,Zacks #1 Rank Additions for Friday  - Tale of the Tape,2010-11-05 09:33:00-04:00,AKRX,neutral
55543.0,"NASDAQ Stocks Hitting 52-Week Highs (CRVL, AKRX, MPEL, RSTI)",2010-11-02 10:42:00-04:00,AKRX,neutral
55544.0,"Benzinga's Top Pre-Market NASDAQ Gainers (ALVR, ITMN, FSLR, AKRX)",2010-10-07 08:29:00-04:00,AKRX,positive
55545.0,"Stocks That Created New 52-Week Highs (AKRX, AMMD, ATRO, CSTR, CORT)",2010-05-05 13:19:00-04:00,AKRX,positive
55546.0,"Stocks That Crossed 52-Week Highs (AKRX, CGNX, DMLP, IPXL, INHX)",2010-05-04 11:27:00-04:00,AKRX,neutral
55547.0,"Benzinga’s Top Pre-Market Gainers (DEAR, CYBS, AKRX, MANH, HBAN)",2010-04-21 09:19:00-04:00,AKRX,positive
55548.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,AKRX,positive
55549.0,"Akorn, Inc. (NASDAQ:AKRX) Value at its Best",2009-11-04 11:05:00-05:00,AKRX,positive
